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Endothelium plays an important role in regulating the activity of the 
underlying vascular smooth muscle. Upon stimulation, endothelium releases a 
variety of endothelium-derived relaxing factors (EDRFs). These include 
endothelium-derived nitric oxide (NO), prostacyclin (PGI2), and a chemically 
unidentified endothelium-derived hyperpolarizing factor (EDHF). The present 
study focuses on EDHF-mediated endothelial function with implications in 
cardiopulmonary surgery. We have aimed to explore 1) the effect of hypoxia-
reoxygenation (H-R); 2) the combined effects of H-R and St Thomas cardioplegic 
solution (ST) on EDHF-mediated relaxation under clinically relevant temperatures; 
and 3) the effect of nicorandil supplementation in solutions under H-R on EDHF-
mediated endothelial function. 
Isometric force study was performed in a wire myograph (for porcine 
coronary micro vessels). In the presence of N^-nitro-L-arginine (L-NNA), 
indomethacin (Indo) and hemoglobin (HbO)，EDHF-mediated relaxation was 
induced by bradykinin (BK) in U46619 evoked precontraction. 
Exposure to hypoxia for 30 minutes or 60 minutes in Krebs solution at 
370c followed by 30-minute reoxygenation significantly reduced BK-induced, 
EDHF-mediated relaxation in both coronary microarteries and cardiac veins and 
the injury is more severe during prolonged H-R. 
In coronary microarteries, exposure to ST solution at 37�C or 4 � C for 60-
min-hypoxia followed by 30-min reoxygenation significantly decreased EDHF-
mediated relaxation and the relaxation was significantly less after exposure to ST 
at 37°C than at 4°C. In cardiac veins, exposure to ST solution at 37�C or 4 � C for 
60-min-hypoxia followed by 30-min reoxygenation also significantly decreased 
X 
Abstract 
EDHF-mediated relaxation while there were no significant differences between 
Krebs and ST regarding the relaxation at either 37°C or 4°C. 
Addition of nicorandil to Krebs solution at 37�C or to ST solution at 37°C 
or 4°C after 60-min hypoxia significantly restored the EDHF-mediated relaxation 
in coronary micro arteries. 
These results suggest that 
1) H-R impairs EDHF-mediated relaxation in both coronary microarteries and 
cardiac veins and the injury is more severe during prolonged H-R; 
2) Under the condition of profound hypothermia (4�C) or normothermia (37°C), 
ST solution does not provide protection to the EDHF-mediated relaxation 
impaired by H-R although its detrimental effect at 37�C is eliminated at 4 � C in 
coronary microarteries; 
3) Under the condition of profound hypothermia (4�C) or normothermia (37°C), 
ST solution does not provide protection to the EDHF-mediated relaxation 
impaired by H-R at 3TC or at 4°C in cardiac veins; 
4) As an additive to Krebs or ST during hypoxia under normothermia or profound 
hypothermia, the nicorandil may restore EDHF-mediated endothelial function. 









前列環素（P G I 2 )及未知化學結構的内皮源性超極化因子（E D H F ) �本研 
究著重于探討内皮源性超極化因子介導的功能及其在心臟外科手術中的意 
義。旨在研究1)缺血再灌注對該因子功能的影響；2)在與臨床相關的溫 










3 7 � C或者4 � C下，緒冠狀微動脈在S T溶液中缺氧6 0分鐘並伴隨3 0 
分鐘的再灌注後，内皮源性超極化因子介導的舒張功能顯著減少，而且在 





在豬冠狀微動脈中， 3 7 � C下，添加尼可地爾於K r e b s中；或者在 














AA Arachidonic acid 
ACh Acetylcholine 
BK Bradykinin 
BKca Large-conductance calcium-activated potassium channels 
cAMP Cyclic adenosine monophosphate 
cGMP Cyclic guanine monophosphate 
ChTX Charybdotoxin 
COX Cyclooxygenase 
CYP Cytochrome P450 
EDHF Endothelium-derived hyperpolarizing factor 
EDRF Endothelium-derived relaxing factor 
EET Epoxyeicosatrienoic acid 





IKca Intermediate-conductance calcium-activated potassium channels 
I-R Ischemia-reperfusion 
KATP channel ATP sensitive potassium channel 
Kca Ca2+-activated K+ channel 
Kir Inwardly rectifying K+ channels 
Kv Voltage-dependent K+ channel 
L - N N A N^-nitro-L-arginine 
NO Nitric oxide 
NOS Nitric oxide synthase 
PGI2 Prostacyclin 
PKA Protein kinase A 
PKG Protein kinase G 
PLC Phospholipase C 
ROS Reactive oxygen species 
SGc Soluble guanylyl cyclase 
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Chapter 1 General Introduction 
Chapter 1 
General Introduction 
Vascular endothelium is a cellular layer lining the blood vessels and has a 
variety of biological functions such as keeping the balance between blood 
coagulation and fibrinolysis, lipoprotein metabolism, and coordinating the 
interaction between platelets and leukocytes. It also plays an important role in 
regulating the activity of the underlying vascular smooth muscle [Vanhoutte, 1989; 
Furchgott, 1984; Vanhoutte, 1998]. During cardiac surgery, the endothelium is 
inevitably exposed to hyperkalemic cardioplegia or organ preservation solutions 
and subjected to ischemia-reperfusion (I-R) injury that has been demonstrated to be 
harmful to the endothelial function [Pearl et al, 1994; Sellke et al, 1993]. 
Endothelial damage may lead to an increase of capillary permeability and organ 
edema, to vasospasm, and to microvascular hypoperfusion and early organ 
dysfunction [Robson, et al., 1995; Pinsky, 1995]. In addition, the effects of 
preservation-related endothelial cell injury in organ transplantation are not only 
limited to early organ dysfunction but may also result in later stage events, e. g., 
graft rejection and chronic transplant arteriopathy [Day, et al., 1995; Chomette, et 
al , 1988]. Due to the importance of the coronary circulation in the post-operative 
cardiac function, prevention of endothelial dysfunction becomes an essential 
clinical issue with the goal of "perfect" heart protection in modem cardiac surgery. 
1.1 The role of endothelium in regulating vascular tone 
Vascular endothelium is a single-cell lining covering the internal surface of 
blood vessels and plays an important role in regulating vascular tone. In response 
to the physiological or pharmacological stimuli, such as shear stress and vasoactive 
agents, endothelium releases endothelium-derived factors including 
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vasoconstrictors and vasodilators. Investigations regarding endothelium-dependent 
relaxation started in 1970,s, since Moncada and Vane proposed prostacyclin 
(PGI2), a product of arachidonic acid (AA) metabolism of endothelium, has 
relaxant effect on vascular smooth muscle [Moncada et al., 1976; Moncada and 
Vane, 1978; Gryglewski et al., 1988]. Further, Furchgott and Zawadski [Furchgott 
and Zawadski, 1980] made the historical finding of endothelium-relaxing factor 
(EDRF) that was later identified as nitric oxide (NO) by Ignarro et al [Ignarro et 
al., 1987]. In addition, studies in recent years showed strong evidence of the 
involvement of the third factor, a chemically unidentified endothelium-derived 
hyperpolarizing factor (EDHF) in the vasorelaxation [Feletou and Vanhoutte, 1988; 
Furchgott and Vanhoutte, 1989; Komori and Vanhoutte, 1990; He et al, 1996; 
Feletou and Vanhoutte, 1996; Mombouli and Vanhoutte, 1997; Vanhoutte, 1998; 
Ge et al, 2000；. 
1.1.1 Nitric oxide (NO) 
In 1980, Furchgott and Zawadzki reported that acetylcholine (ACh) causes 
relaxation of isolated blood vessels only in the presence of an intact endothelial 
cell layer [Furchgott and Zawadzki, 1980]. In 1977, Katsuki et al discovered that 
NO release caused by nitrates relaxes smooth muscle cells [1977]. In 1987, 
Ignarro et al proposed that EDRF is identical to NO [1987]. The involvement of 
endothelium in coordination of vasoactive factors and the important role of 
endothelium in regulation of the vascular tone have been recognized. 
NO is a relatively stable gas, with ability to easily diffuse through the cell 
membrane. It plays an important role in many physiological processes and is 
important in regulation of vascular tone, neurotransmission, and various 
homeostatic events [Nathan and Xie, 1994]. L-arginine is a substrate for NO 
synthesis. NO and L-citmlline are produced after induction of L-arginine 
2 
Chapter 1 General Introduction 
metabolism by NO synthase (NOS). When L-arginine is split, oxygen and 
NADHP are used, NH2 group of L-arginine is transformed to NOH group, from 
which NO separates in the process of L-citmlline formation (Fig. 1.1). L-arginine 
reserve is accumulated from extracellular space and by intracellular synthesis. 
There are at least three NOS isoforms. NOS-1, also referred to as neuronal 
NOS (nNOS), is found in high levels in neuronal cells as well as some non-
neuronal tissue. This isoform is activated by calmodulin during conditions of 
elevated calcium, and is thought to produce NO that acts as a neurotransmitter 
Bredt and Snyder, 1992]. NOS-2 is also referred to as macrophage or inducible 
NOS (iNOS), since it is induced in multiple cell types, including macrophages, 
hepatocytes, smooth muscle cells, and others. In resting cells, this enzyme is 
generally not present until it is produced in response to lipopolysaccharide and 
cytokine stimulation as a cytotoxic response mechanism [Nathan, 1992]. The 
NOS-2 enzyme is the only NOS isoform that is activated independent of calcium, 
meaning that the enzyme is always bound to calcium/calmodulin once synthesized. 
NOS-3, also called endothelial NOS (eNOS), is the enzyme originally found to 
produce EDRF [Nathan, 1992]. Similar to NOS-1, NOS-3 is also activated by 
elevated intracellular calcium levels and calmodulin binding. NOS-1 and NOS-3 
have been commonly referred to as constitutive NOS enzymes due to their 
constitutive expression and regulation by calcium/calmodulin. 
In the vascular system, NO diffuses out of endothelial cell and a portion of 
it arrives at the underlying smooth muscle cell layer. NO causes relaxation of 
vascular smooth muscle through the cGMP-PKG-dependent pathway. In general, 
the stimulation of endothelial-cell receptors by a chemical agonist results in 
activation of one or more isoforms of phospholipase C (PLC), with consequent 
increase in the formation of 1, 4, 5- inositoltrisphosphate (IPs)- Transient 
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2+ 
elevations of IP3 lead to transient increase in the levels of intracellular free Ca , 
accompanied by an activation of eNOS in blood vessels, and result in activation of 
soluble guanylyl cyclase (sGC) in smooth muscle cells and production of cyclic 
guanosine triphosphate (cGMP). cGMP decreases vascular tone by lowering 
cytosolic Ca2+ levels in smooth muscle cells. Although mechanisms by which 
cGMP regulates cytosolic Ca^^ are complex, an important role for the cGMP-
dependent protein kinase in regulating Ca^^ has been proposed. cGMP-dependent 
protein kinase G (PKG) has been shown to regulate several pathways that control 
2+ 
cytosolic Ca2+ levels: IP3 production and action [Schlossmann, et al, 2000], Ca -
ATPase activation, and activation of Ca^^-activated K+ channels (Kca channel). 
The pleiotropic action of cGMP-dependent protein kinase is proposed to occur 
through the phosphorylation of important proteins that control several signaling 
pathways in smooth muscle cells. One potential target for cGMP-dependent 
protein kinase is the class of okadaic acid-sensitive protein phosphatases that 
appears to regulate K+ channels among other potentially important events to reduce 
cytosolic Ca2+ and tone. In addition, cytoskeletal proteins are targets for cGMP-
dependent protein phosphorylation, and it is now appreciated that the cytoskeleton 
may play a key role in signal transduction [Lincoln, et al., 1994；. 
The second mechanism of endothelium-dependent relaxation may be 
mediated by hyperpolarization of the membrane of the smooth muscle cell [Cohen 
and Vanhoutte, 1995]. NO in solution or nitrovasodilators can hyperpolarize 
smooth muscle of several different isolated blood vessels, including the small 
mesenteric artery [Waldron and Garland, 1994] and the aorta [Vanheel et al, 1994] 
of the rat, the uterine [Tare et al, 1990] and coronary artery of the guinea pig 
[Parkington et al, 1993], and the basilar artery of the rabbit [Rand and Garland, 
1992]. One mechanism by which NO could hyperpolarize smooth muscle is by 
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increasing cGMP, which in turn causes protein kinase-dependent activation of Kca 
channels [Taniguchi et al, 1993; Robertson et al, 1993; White et al, 1993]. In 
addition, ATP-dependent potassium (KATP) channels appear to be activated by NO, 
through a cGMP-dependent mechanism [Kubo et al, 1994; Murphy and Brayden, 
1995a]. Apart from the cGMP-dependent manner, another potential 
hyperpolarizing action of NO is its ability to stimulate the Na+-K+-ATPase pump 
directly [Gupta et al, 1994]. Further, Bolotina et al demonstrated that NO can 
directly activate Kca channels and increase the outward potassium current of 
vascular smooth muscle [Bolotina et al, 1994；. 
NH2+ O2 H2O NOH O2 H2O O 
II A II 牛 II 
R.N-C-NH2 T 一 R-N-C-NH2 ^ R-N-C-NH2 + A^ O 
H I J H I 1 H 
NADPH NADP+ NADPH NADP+ 
L-arginine N-hydroxy-L-arginine L-citruline 
Fig 1.1 Nitric oxide (NO) formation from L-arginine by NO synthase 
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Fig 1.2 Schematic demonstration of the pathway of nitric oxide (NO) -mediated 
endothelium-dependent relaxation. Agonist acting with endothelial membrane 
receptors (R) or shear stress cause G protein (G)-mediated increases in calcium 
(Ca2+) influx and phospholipase C (PLC)-mediated hydrolysis of phosphotidyl 
inositol bisphosphate (PIP2), yielding inositol triphosphate (IP3), which releases 
Ca2+ from intracellular stores. The resulting increase in Ca^^ activates nitric oxide 
synthase (NOS) to produce NO. NO induces relaxation of the vascular smooth 
muscle cell through cGMP-PKG-dependent pathway, and hyperpolarization by the 
activation of large-conductance calcium-activated potassium channels (BKca) and 
ATP-sensitive potassium channels (KATP). 
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1.1.2 Endothelium-derived hyperpolarizing factor (EDHF) 
In general, hyperpolarization of smooth muscle produces relaxation by 
2+ 
reducing both the open probability of voltage-dependent Ca channels and the 
turnover of intracellular phosphatidylinositides, thus decreasing the intracellular 
Ca2+ concentration [Nelson et al, 1990]. Since the first evidence that stimulation of 
vascular endothelium evoked hyperpolarization and relaxation of the smooth 
muscle was observed in the guinea pig mesenteric artery [Bolton et al., 1984], the 
hyperpolarization phenomenon has been confirmed in various blood vessels. 
Feletou and Vanhoutte [1988] and Chen et al [1988] independently described 
endothelium-dependent hyperpolarization of vascular smooth muscle cells and 
postulated the existence of EDHF. Since endothelium-dependent relaxation is 
mediated primarily by NO, PGI2 and EDHF, EDHF-mediated relaxation is defined 
as a relaxation that is resistant to combined blockade of COX and NOS [Nagao and 
Vanhoutte, 1992]. 
Despite the fact that the existence of EDHF was proposed in 1988, the 
nature of EDHF remains to be identified. The question of the chemical identity of 
EDHF has received considerable attention; however, no consensus has been 
reached. Possible candidates for EDHF include epoxyeicosatrienoic acids (EETs) 
that are metabolites of cytochrome P-450 epoxygenases [Fisslthaler et al, 1999], 
endothelium-derived K+ ions [Edwards et al, 1998], and hydrogen peroxide 
[Matoba et al, 2000]. It is also suggested that endothelium-dependent 
hyperpolarization is achieved by electrical communications between endothelial 
and smooth muscle cells through gap junctions [Yamamoto et al, 1998; Edwards et 
al, 2000]. Thus, more than one EDHF appear to exist and the contribution of each 
EDHF to endothelium-dependent relaxation may vary depending on the species 
tested and the vessels used. 
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Myoendothelial gap junctions 
Up to date, no single factor has clearly been identified as the "universal" 
physiological mediator of the EDHF phenomenon. Gap junctions not only couple 
endothelial cells to endothelial cells, and smooth muscle cells to smooth muscle 
cells, but also couple smooth muscle cells to endothelial cells, thus providing a 
low-resistance electrical pathway between these two cell layers [Christ et al, 1996 . 
An alternative hypothesis, therefore, is that an initiating endothelial 
hyperpolarization is conducted electrotonically to subjacent smooth muscle cells 
2+ 
via gap junctions, resulting in the closure of the voltage-dependent Ca channels 
that maintain the Ca^^ influx necessary for contraction. In support of this idea, a 
large number of experiments have been performed. In 1990, Beny reported that 
substances producing endothelium-dependent hyperpolarization of vascular 
smooth muscle cells also hyperpolarize endothelial cells with the same time-course 
Beny, 1990]. Another study by Emerson and Segal has illustrated the importance 
of the endothelial cell layer as the pathway for the endothelium-dependent 
hyperpolarization signal to the smooth muscle cell. It was found that the 
conduction of the ACh-mediated hyperpolarization and vasodilation of the hamster 
retractor muscle feed artery was interrupted by damage to the endothelial cells, but 
not the smooth muscle cell layer [Emerson and Segal, 2000b]. In arterioles and 
feed arteries from the retractor muscle of the hamster, simultaneous measurements 
of the membrane potential in endothelial and smooth muscle cells show that 
electrical signals travel freely and bidirectionally between the two layers. These 
electrical signals are associated with vasomotor responses, and hyperpolarization 
originating in a single endothelial cell can drive the relaxation of smooth muscle 
cells throughout an entire arteriolar segment [Emerson and Segal, 2000a; and 
Emerson and Segal, 2001]. Cell activation by an agonist facilitates myo-
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endothelial gap junctional communication because a more pronounced myo-
endothelial coupling is observed in ACh-stimulated arteries than in arteries in 
which either smooth muscle or endothelial cells were stimulated by injection of a 
negative current [Emerson and Segal, 2000a . 
Are gap junctions a privileged site for the transfer of electrical charges or 
do they transfer a messenger molecule (e. g. EDHF)? Studies showed that in 
various microcirculatory beds, the link between the EDHF phenomenon and the 
spread of an electric current through myoendothelial gap junction exists. For 
example, in submucosal arterioles of the guinea-pig small intestine, Ach induces 
outward currents in endothelial cells and smooth muscle cells that are blocked by 
the combination of charybdotoxin (ChTX) plus apamin. After the administration 
of blockers of gap junctions, ACh elicits an outward current in endothelial cells but 
no longer in the smooth muscle cells, which suggests that the two cell types are 
connected electrically and form a functional syncytium [Yamamoto et al, 1999; 
Coleman et al, 2001]. In other microcirculatory beds, such as the retractor muscle 
of the hamster, an electrotonic current spread from endothelial cells to smooth 
muscle cells seems to be the most likely explanation of the EDHF phenomenon 
[Emerson and Segal, 2001]. The possibility that gap junctions facilitate the 
diffusion of a 'hyperpolarizing factor', such as cAMP [Chaytor et al, 2001], from 
the endothelium to the smooth muscle raises other questions. First, if cAMP were 
transferred from endothelial cells to smooth muscle cells the overall response 
would be similar to that elicited by PGI2 and should be sensitive to an inhibitor of 
KATP channels. Second, any 'factor' transferred via gap junctions would have to be 
hydrophilic (to allow its passage through the aqueous pore) and should also be 
actively regenerated because a significant dilution of the factor would occur from 
the site of its production during its rapid distribution throughout the smooth muscle 
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layers of the vascular wall. Therefore, should cAMP play a role in the EDHF 
response, it is more likely that it is involved in the dynamic regulation of gap 
junctional communication than acting as an EDHF per se. 
However, in large blood vessels, the suggestion that EDHF-mediated 
responses require functional myo-endothelial gap junctional communication is 
more controversial. Myoendothelial gap junctions occur in greater density in 
resistance compared with conduit arteries [Daut et al, 1994] and this may explain 
the predominance of endothelium-dependent hyperpolarization in the resistance 
vasculature [Shimokawa et al, 1996]. Sandow and Hill have provided anatomical 
support for this with a serial-section electron microscopic study of proximal versus 
distal rat mesenteric arteries and have demonstrated a significantly greater density 
of myoendothelial gap junctions in the distal arteries [Sandow and Hill, 2000；. 
The specificity of gap junction inhibitors (carbenoxolone, glycyrrhetinic acid, 
halothane and heptanol) is often questionable. By contrast, peptides with 
sequences similar to a portion of the extracellular loop of the connexon proteins 
[the so-called gap peptides (e. g. GAP27)] can inhibit gap junctions [Chaytor et al, 
1998; Chaytor et al, 2001]. Although such peptides are assumed to inhibit 
myoendothelial gap junctions, this has merely been inferred from their ability to 
reduce dye coupling in cultured cells that express only connexin 43 and 40 
"Chaytor et al, 2001]. However, electrical coupling between endothelial cells and 
smooth muscle cells can be observed in the absence of dye coupling [Coleman et al, 
2001]. Furthermore, the assumption that gap junction inhibitors are acting at the 
level of myoendothelial junctions could be mistaken. For example, in the porcine 
coronary artery, endothelium-dependent hyperpolarizations to substance P can be 
recorded in the smooth muscle cells situated close to the intimal layer or close to 
the adventitia. GAP27 inhibits the hyperpolarization in the outer layer while the 
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response remains unaffected in the intimal layer, suggesting that smooth muscle 
rather than myoendothelial gap junctions were targeted by the peptide [Ewards et 
al, 1998]. Clearly, there is need for further investigation of the function of gap 
junctions and for a better understanding of the mechanism of action of these gap 
junction inhibitors. 
EETs 
A number of enzymes, including cyclooxygenase (COX), lipoxygenase, 
and cytochrome P450 epoxygenases (CYP), metabolize arachidonic acid (AA) into 
products that affect the vasculature. EETs (5, 6-; 8, 9-; 11, 12- and 14, 15-EET) 
are AA-derived products of CYP that appear to play an important role in the 
regulation of vascular homeostasis [Fisslthaler et al, 1999]. Evidence has been 
accumulated in support of the hypothesis that EETs are an EDHF in at least some 
vascular beds [Campbell and Harder, 1999；. 
In the bovine coronary artery, all four EETs are proposed to contribute 
equally [Campbell et al, 1996]. Fisslthaler et al demonstrated that the transfection 
of porcine coronary arteries with antisense oligonucleotides against CYP 
attenuated EDHF-mediated coronary vasodilatation and these data are suggestive 
that a CYP product is an EDHF [Fisslthaler et al, 1999]. Evidence in support of a 
role for AA product in endothelium-dependent hyperpolarization has also been 
provided by a study with porcine coronary arteries, where a transferable 'EDHF' 
could be detected by bioassay and its ability to hyperpolarize smooth muscle cells 
was demonstrated [Popp et al, 1996; Yang et al, 2003]. Popp et al also 
demonstrated that the effects of this putative factor were inhibited by the CYP 
inhibitors clotrimazole and 17-octadecynoic acid and that the CYP product 5, 6-
EET acid induced a hyperpolarization of smooth muscle cells. In addition, the 
induction of CYP activity by beta-naphthoflavone significantly enhanced the 
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endothelium-dependent hyperpolarization response. Although classical CYP 
inhibitors are nonspecific, new selective and structurally different compounds do 
inhibit EDHF-mediated responses in some arteries [Imig et al, 2001:. 
In general, EETs are expected to relax coronary arteries and hyperpolarize 
smooth muscle cells by increasing the open-state probability of Kca channels that 
are sensitive to tetraethylammonium, ChTX, or iberiotoxin [Campbell et al, 1996; 
Fulton et al, 1998; Fisslthaler et al, 1999]. It should also be noted that EETs have 
been reported to promote endothelial cAMP synthesis via activation of adenylyl 
cyclase [Node et al, 2001; Popp et al, 2002]. In porcine coronary endothelium, BK 
promotes endogenous synthesis of 11,12-EET and enhances inter-endothelial gap 
junctional communication through signaling pathways that involve cAMP-
dependent PKA-mediated phosphorylation events that are also activated by 
exogenous 11,12-EET [Node et al, 2001; Popp et al, 2002]. 
Despite of the fact that EETs share many of the known properties of EDHF, 
the hypothesis that a CYP product functions as an EDHF has still been challenged 
for several reasons. First, many of the CYP inhibitors used have considerable non-
specific actions, notably on K channels. Edwards et al [Edwards et al, 1996] have 
reported that miconazole and other imidazoles are non-specific inhibitors of CYP 
and also block K channels, whereas the substrate of CYP 17-ODYA, only inhibited 
hyperpolarization of vascular smooth muscle, appeared to show specificity towards 
CYP. Somewhat similar data have also been provided by Vanheel et al and such 
data clearly indicate the need to verify the specificity of the pharmacological 
probes used in such studies [Vanheel et al, 1999]. Furthermore, although the data 
presented by Fisslthaler et al [Fisslthaler et al, 1999] can be interpreted as 
supportive of a role for a CYP product being an EDHF, the data could also be 
interpreted as reflecting an autocrine function of an endothelium-derived CYP 
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product that enhances the synthesis/release of a non-arachidonic acid EHDF that 
mediates the hyperpolarization/vasodilatation of smooth muscle. Further, one 
possibility that might reconcile many of the experimental observations is that 
hyperpolarization of endothelial cells might be partly regulated by activation of the 
CYP. For example, EETs might modulate endothelial Ca^ "" influx in response to 
Ca2+-store depletion [Hoebel et al, 1997] and might facilitate the activation of 
endothelial K+ channels by increasing their sensitivity to Ca^^ [Graier et al, 1995; 
Mombouli et al, 1999]. Additionally, EETs also exert a biphasic change in gap 
junctional communication between endothelial cells [Popp et al, 2002] and their 
effect on myo-endothelial gap junctions is currently under investigation. Therefore, 
in coronary arteries, EETs could be reclassified as intracellular second messengers 
crucial to the initiation and transmission of endothelial cell hyperpolarization, and, 
as a consequence, to EDHF-mediated hyperpolarization and relaxation of vascular 
smooth muscle cells. An additional problem in accepting that an EET may be an 
EDHF is that although EET can hyperpolarize smooth muscle, they seem to do so 
via the activation of iberiotoxin-sensitive BKca channels [Hu and Kim. 1993], 
whereas the hyperpolarization mediated by ACh is usually only significantly 
inhibited by a combination ofChTX and apamin [Edwards et al, 1998；. 
Potassium ion 
A small increase in extracellular K � i s well known to cause vascular smooth 
muscle relaxation [Knot et al, 1996]. Edwards et al measured potassium, Ko, in the 
extracellular space between endothelial and vascular smooth muscle cells in rat 
hepatic artery with a K+-sensitive microelectrode and reported an ACh-mediated 
increase in Ko from 4.6 to 11.6 mmol/L [Edwards et al, 1998]. Additional 
evidence in support of the hypothesis that an increase in extracellular potassium 
can mimic the effect of EDHF was also presented by Edwards et al and was based 
13 
Chapter 1 General Introduction 
on the measurement of the membrane potential of both endothelial and vascular 
smooth muscle cells with glass microelectrodes. ACh was shown to hyperpolarize 
both vascular and endothelial cells and hyperpolarization of the endothelial cell 
was inhibited by a combination of apamin and ChTX and vascular 
hyperpolarization by a combination of ouabain and barium. These data led to the 
conclusion that apamin-sensitive small conductance calcium-activated K+ channels 
(SKca) and ChTX-sensitive intermediate conductance calcium-activated K+ 
channels (IKca) on endothelial cells regulate the release of EDHF and the ouabain-
sensitive electrogenic Na+/K+-ATPase and inward rectifying K+ channel (Kir) on 
the vascular smooth muscle mediate the vascular actions of EDHF [Edwards et al, 
1998]. It has therefore been suggested that the efflux of K+ ions acts as an EDHF 
to mediate hyperpolarization and relaxation of arterial smooth muscle. In vivo 
most arteries are contracted to some extent depending on the level of sympathetic 
activation or of circulating hormones. However, in healthy men infusion of barium, 
ouabain, or their combination reduce brachial artery blood flow and K+ infusion 
produces vasodilatation sensitive to these inhibitors [Dawes et al, 2002], 
suggesting that K+ as an EDHF could play a physiological role. 
Data from a number of laboratories have challenged the hypothesis that K+ 
is the universal EDHF. In a study of guinea-pig third-order mesenteric artery and 
the middle cerebral artery, Dong et al provide contrasting data. In neither vessel 
would the addition of low concentrations of K+ evoke relaxation. Although 
ouabain greatly attenuated EDHF-mediated relaxation in the mesenteric arteries, it 
enhanced relaxation in the cerebral vessels [Dong et al, 2000]. Barium and 
ouabain reversed K+-mediated vasorelaxation whereas EDHF response was 
insensitive to the combination of barium and ouabain in the human subcutaneous 
artery and the porcine coronary microartery [Coats et al, 2001; Matoba et al, 2003]. 
14 
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These data suggest that, although an increase in extracellular K+ may be a 
contributing factor to EDHF-mediated relaxation in some vascular beds, K+ is 
unlikely to be the primary mediator in all vessels. 
Hydrogen peroxide 
With increase in endothelial intracellular calcium concentrations, vascular 
endothelial cells have a capacity to produce hydrogen peroxide (H2O2) from 
several intracellular sources, including eNOS, COX, lipoxygenases, CYP and 
NADPH oxidases [Fleming et al, 2001; Ullrich and Bachschmid, 2000]. The role 
of reactive oxygen species (ROS) in endothelium-dependent relaxations has been 
investigated since the identification of NO as an EDRF [Rubanyi and Vanhoutte, 
1986; Mugge et al, 1991]. As mentioned above, various endothelial oxidases could 
produce superoxide [Katusic, 1996; Fleming et al, 2001]. Superoxide is degraded 
to H2O2 spontaneously or through superoxide dismutase-dependent dismutation. 
Subsequently, H2O2 is catalyzed by endogenous peroxidases into H2O and O2 or 
converted to hydroxyl radical through the Fenton reaction. Rubanyi and Vanhoutte 
[1986] reported that superoxide attenuates endothelium-dependent relaxations and 
that H2O2 causes endothelium-dependent and -independent relaxations. In contrast, 
hydroxyl radical causes endothelium-dependent contractions [Auch-Schwelk et al, 
1989]. Because it is difficult to handle ROS, previous studies mainly employed 
various ROS scavengers when examining vascular responses. Matoba et al. [2000: 
also utilized catalase, an endogenous peroxidase, to assess the role of H2O2 in 
endothelium-dependent hyperpolarizations and found that catalase inhibited 
EDHF-mediated, endothelium-dependent relaxations and hyperpolarizations 
resistant to Indo or L-NNA. The specificity of catalase was confirmed by the 
finding that enzymatically inactivated catalase lost the inhibitory effect on the 
EDHF-mediated responses. Involvement of hydroxyl radical was ruled out 
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because deferoxamine, which inhibits the formation of the radical, did not affect 
the EDHF-mediated responses. Based on those observations, it is likely that H2O2 
acts as the termed EDHF in certain vasculatures. 
The mechanism of HiOi-induced hyperpolarization appears to be complex, 
depending on the blood vessel used and the type of vascular wall cells examined. 
In porcine coronary arteries, H2O2 activates Kca channels either by direct 
modulation of the channels or by a cGMP- [Hayabuchi et al, 1998] or 
lipoxygenase-mediated mechanism [Barlow and White et al, 1998; Barlow et al, 
2000]. In rat cerebral arterioles, H2O2 also activates Kca channels and causes 
relaxations [Sobey et al, 1997]. In contrast, H2O2 activates KATP channels to cause 
relaxations in cat cerebral arterioles and piglet pial arterioles [Wei et al, 1996; 
Lacza et al, 2002]. In mouse mesenteric arteries, H2O2 activates 
tetrabutylammonium-sensitive Kca channels to cause relaxations and 
hyperpolarizations of endothelium-stripped vascular smooth muscle, as is the case 
with endogenous EDHF [Matoba et al, 2000]. In human coronary micro vessels, 
Kca channels sensitive to ChTX plus apamin is activated by H2O2 as an EDHF 
"Miura et al, 2003]. It is also reported that H2O2 elicits hyperpolarization of human 
endothelial cells by activating Kca channels on those cells [Bychkov et al, 1999]. 
Thus, it remains to be examined in future studies what type of K+ channel is 
involved, which type of the cell is hyperpolarized, and whether H2O2 directly 
activates the channels or indirectly does so through second messengers. 
On the other hand, it has been reported that catalase failed to inhibit EDHF-
mediated response in the porcine coronary artery [Beny and von der Weid, 1991; 
Pomposiello et al, 1999], the rabbit iliofemoral artery [Chaytor et al, 2003], and 
the human radial artery [Hamilton et al, 2001], indicating that H2O2 may not be 
EDHF, at least in certain vessels. 
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Possible mechanisms involved in EDHF-mediated function 
The elusive nature of EDHF has hampered detailed study of the 
mechanisms that underlie the EDHF hyperpolarization and relaxation. Most 
studies have relied on a pharmacological approach in which interpretations of 
results can be confounded by limited specificity of action of the drugs used. 
2+ . _j_ 
Nevertheless, small-, intermediate-, and large-conductance Ca -activated K 
channels (SKca，IKca, and BKca, respectively) have been implicated, with inward 
rectifier K+ channels (KIR) and Na+/K+-ATPase also suggested by some studies. 
Earliest studies to identify the ionic mechanisms underlying EDHF used 
blockers of various ion pathways. Indeed, a hallmark of the EDHF-mediated 
response is its abolition by the combination of apamin (a specific inhibitor of SKca 
channels) plus ChTX (a nonselective inhibitor of BKca and IKca channels, and of 
some voltage-dependent K+-channels (Kv)) [Corriu et al, 1996; Zygmunt and 
Hogestatt, 1996; Ge et al, 2000], although either toxin can be effective alone in 
some circumstances [Murphy and Brayden, 1995b; Miura et al, 1999]. The effect 
of apamin can be mimicked by scyllatoxin, a structurally distinct SKca channel 
inhibitor, indicating that SKca channels are involved in endothelium-dependent 
hypeipolarizations [Corriu et al, 1996]. However, although iberiotoxin (a specific 
inhibitor of BKca channels) can abolish NO- and PGIi-independent vasodilatation 
in some vascular beds in vivo [Nishikawa et al, 1999; Huang et al, 2000], in 
arteries in which the combination of ChTX and apamin is essential to inhibit 
responses, iberiotoxin cannot substitute for ChTX [Chataigneau et al, 1998]. This 
excludes a pivotal role for BKca channels in many EDHF-mediated responses. 
Further, the involvement of IKca and SKca channels in the EDHF response raises 
the critical question of where these channels are located. An endothelial site for 
the initiation of the EDHF hyperpolarization suggests that the IKca and SKca 
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channels are located in endothelial rather than smooth muscle cells. Consistent 
with such oberservation, electrophysiology, immunohistochemistry, and expression 
analysis reveal an abundance of IKca and SKca channels in endothelial cells 
Bychkov et al, 2002; Bumham et al, 2002; Taylor et al, 2003; Marchenko and 
Sage, 1996]. BKca, which are mainly expressed in the vascular myocytes, seem to 
play a minor role in the endothelial cell of a given vasculature [Zygmunt et al, 
1997; Quignard et al, 2000; Gauthier et al, 2002; Ge et al, 2000; Yang et al, 2003]. 
Using low concentration of barium to specifically block Km and ouabain to 
block the Na+/K+-ATPase, a number of studies provided evidence that Km and 
Na+/K+-ATPase are involved in the EDHF-mediated hyperpolarizaion [Beny and 
Schaad, 2000; Savage et al, 2003], whereas others provided evidence against this 
hypothesis [Drummond et al, 2000; Lacy et al, 2000；. 
Additionally, activation of KV channels and KATP channels has been 
suggested to be involved in the function of EDHF in certain vasculatures [Eckman 
et al, 1998; Shimizu and Paul, 1997; Plane and Garland, 1993]. However, this is 
not supported by other studies as mentioned above. 
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Fig 1.3 Schematic representation of the pathway of endothelium-derived 
hyperpolarizing factor (EDHF)-mediated endothelium-dependent relaxation. 
Under shear stress or stimulated by an agonist, intracellular calcium concentration 
increases in the vascular endothelium, leading to the release of EDHFs. EETs, a 
candidate of EDHF, generated from arachidonic acid (AA) by cytochrome P450 
(CYP450), induce hyperpolarization and relaxation of vascular smooth muscle cell 
through the activation of IKca, BKca on endothelium and BKca on smooth muscle 
cell. Myoendothelial gap junctions also appear to behave as EDHF by passively 
conducting endothelial hyperpolarization to underlying smooth muscle cell. 
Potassium ion (K+) hyperolarizes and relaxes the vessels by activating the inwardly 
rectifying K+ channels (Kir) and Na+-K+ pump of smooth muscle cells. 
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1.1.3 Prostacyclin (PGI2) 
PGI2 was the first relaxing factor discovered. In 1976, Moncada et al. 
described an anticlotting agent that was also capable of relaxing vascular smooth 
muscle [Moncada et al, 1976]. They called the entity PGX which, soon after, was 
identified as PGI2 [Moncada et al, 1977]. PGI2 is lipid soluble and highly unstable 
in the body and thus it leaves the endothelial cell following its production and acts 
as a local anticoagulant and vasodilator. 
In response to chemical agonists, mechanical shear stress, and 
pathophysiological conditions such as hypoxia or ischemia, the enzyme 
phospholipase A2 in endothelial cells converts membrane phospholipids to AA that 
is subsequently metabolized to PGI2, thromboxane A2 , and several prostaglandins 
(PGE2, PGF2, PGD2 etc.) by COX. PGI2 causes vessel relaxation predominantly 
via the adenylyl cyclase/cyclic-AMP transduction system [Kukovetz et al, 1979; 
Ignarro et al, 1985]. Interaction between PGI2 and its receptor in the plasma 
membrane of vascular smooth muscle leads to activation of adenylyl cyclase (AC) 
and an increase in the production of cAMP [Miller et al, 1979]. cAMP activates 
protein kinase A (PKA) which phosphorylates selected target proteins and leads to 
the extrusion of Ca^ "" from the cytosol [Raeymaekers et al, 1990] and a reduction of 
the sensitivity of the contractile apparatus to C a � . [Bukoski et al, 1989; Morgan 
and Morgan, 1984]. Apart from this, PGI2 is also reported to hyperpolarize the 
membrane potential of vascular smooth muscles by several different mechanisms. 
These mechanisms are 1) involvement of KATP channels [Murphy and Brayden, 
1995b; Parkington et al, 2004]; 2) activation of BKca channels by a mechanism 
involving cAMP-dependent-PKA-induced phosphorylation of the channels 
[Schubert et al, 1996; Schubert et al, 1997; Clapp et al, 1998]; and 3) activation of 
4-AP-sensitive delayed rectifier K+ channels [Li et al, 1997]. In addition, a recent 
20 
Chapter 1 General Introduction 
study also suggested that PGIi-induced relaxation was partially mediated by the 
activation of both Kca and Kv channels in rabbit cerebral arteries [Dong et al., 
1998]. 
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Fig 1.4 Schematic demonstration of the pathway of prostacyclin [PGI2]-mediated 
endothelium-dependent relaxation. Under shear stress or stimulated by an agonist, 
intracellular calcium concentration increases in the vascular endothelium, leading 
to activation of phospholipase A2 to release arachidonic acid (AA) that is quickly 
converted to PGI2 by cyclooxygenase (COX). PGI2 induces relaxation of vascular 
smooth muscle cell through cAMP-PKA-dependent pathway and hyperpolarization 
by activation of ATP-activated potassium channels (KATP) or Ca^^-activated 
potassium channels (Kca). 
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1.2 EDHF-mediated endothelial function in coronary 
circulation 
Blood flow and blood pressure are determined by an integration of reflex, 
humoral, and local vascular control mechanisms. Knowledge of these mechanisms 
has mushroomed over the past 15 years, particularly in the area of local 
endothelium-dependent vascular control. As mentioned above, it is now well 
established that the endothelium plays a critical role in the regulation of coronary 
vasomotor tone and homeostasis by releasing of at least three EDRFs: NO, PGI2, 
and EDHF. NO is probably the most important mediator for maintaining the 
vascular tone, particularly in the large vessels. PGI2 is considered to have little 
contribution to endothelium-dependent vasodilatation in the coronary circulation 
since the additional inhibitor of COX does not change BK-induced response in 
coronary arteries from animals and humans [Parkinton et al., 1993; Mombouli and 
Vanhoutte, 1997; Buus et al., 2000; Ge et al., 2000; Liu et al., 2000; He and Liu, 
2001, Yang et al, 2003]. In contrast to NO and PGI2, EDHF contributes more in 
small resistance vessels than in large conduit arteries. In many vessels and, 
notably, in the resistance vasculature, the pharmacological inhibition, or genetic 
'knockout', of the synthesis of NO (or inhibition of PGI2) does not greatly affect the 
endothelium-dependent relaxation response to either chemical (i. e. ACh, BK) or 
mechanical (shear stress) stimulation. A change in membrane potential of just a 
few mV can result in a substantial change in vessel diameter [Brayden and Nelson, 
1995; Nelson and Quayle, 1995] and, thus, it can be predicted that the release of an 
EDHF, a putative opener of K+ channels, will make an important contribution to 
the regulation of vascular tone. Furthermore, hyperpolarization of the smooth 
muscle will, in comparison with cellular events mediated by second messengers, 
produce a rapid effect on blood flow. In addition, because the contribution of 
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EDHF to endothelium-dependent vasodilatation is most apparent in resistance 
vessels, it may be anticipated that any intervention that leads to a diminution in the 
release of EDHF could critically affect the regulation of organ blood flow, thus 
contributing to pathophysiological states such as hypertension [Vazquez-Perez et al, 
2001], diabetes [Triggle et al, 2004], or cardioplegic arrest [He et al, 1996； • 
1.2.1 Role of EDHF in coronary microarteries 
Studies of isolated organs and blood vessels revealed that NO is the 
primary mediator of endothelium-dependent responses to many vasodilator agents. 
However, the importance of the non-NO, non-PGIi EDRF in mediating or 
modulation responses to vasoactive hormones and, thereby, regulating blood flow 
and perfusion pressure, can not be overlooked. It has been demonstrated that in 
many species including the human, there is a considerable proportion of coronary 
vasodilatation resistant to inhibitors of NOS and COX, which is accompanied by 
hyperpolarization of membrane potential, but not by an increase in intracellular 
levels of cyclic nucleotides in vascular smooth muscle cells [Feletou and 
Vanhoutte, 1988; Furchgott and Vanhoutte, 1989; Cohen and Vanhoutte, 1995]. In 
addition, EDHF plays an increasingly prominent role in vasodilation as arterial 
diameter decreases and is thus likely to be important in tissue perfusion. There is 
also evidence that EDHF-mediated vasodilatation is negatively regulated by NO 
not only in vitro, but also in vivo [Bauersachs et al, 1996; Nishikawa et al, 2000；. 
Therefore, EDHF is proposed to serve as a back-up vasodilator when NO 
production is impaired in circulatory system. 
Based on the fact that NOS inhibitors could not completely block the 
production of NO by direct measurement with porphyrinic microsensor technique 
[Simonsen et al, 1999; Cohen et al, 1997; Ge et al, 2000; Liu et al, 2000; He and 
Liu, 2001; Yang et al, 2003], at least a portion of the effect of so called “EDHF， 
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was due to the residual NO resistant to NOS inhibitors. Further application of the 
NO scavenger HbO abolished the residual NO release [Ge et al., 2000]. Only 
under this condition, the relaxation and hyperpolarization are due to EDHF [Ge et 
al., 2000]. 
1.2.2 Role of EDHF in cardiac veins 
Studies have revealed that the cardiac vein has a higher beta-adrenoceptor-
mediated contractility and weaker beta-adrenoceptor-mediated relaxation 
compared with the coronary artery [Saetrum and Edvinsson, 1997] and its 
responses to ACh, serotonin, and noradrenaline are opposite or of a significantly 
different magnitude when compared with the respective arteriolar responses 
Sellke and Dai, 1993]. However, in contrast to the well-studied arteries, there are 
limited studies of endothelium-mediated regulation of smooth muscle cells in the 
coronary venous system. In the presence of the NOS inhibitor, the contribution of 
membrane hyperpolarization to the endothelium-dependent relaxation was firstly 
demonstrated in femoral vein of rat [Nagao and Vanhoutte, 1991]. Subsequently, a 
non-PGL2 and non-NO-mediated endothelium-dependent relaxation was further 
addressed in human omental veins in response to substance P [Wallerstedt and 
Bodelsson, 1997]. Recently, studies on the human dorsal hand vein in response to 
isoproterenol, a selective Pi-adrenoceptor agonist, revealed that the contribution of 
EDHF may be involved in the vasodilatation when NO formation was abolished by 
high concentration of the NOS blocker [Schindler et al., 2004]. 
Our laboratory has demonstrated that in the human saphenous vein both 
basal and stimulated release of NO exists and that EDHF-mediated 
hyperpolarization plays a role [Liu et al, 2000; Liu et al, 2001]. Further, it was 
demonstrated that both NO and EDHF are involved in the regulation of the 
vascular tone in the coronary arterial and venous systems although the amount of 
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NO release and the EDHF-mediated relaxation and associated hyperpolarization 
are less significant in the vein than in the artery in the coronary system [Zhang et al, 
2004]. In addition, it was found that similar to the artery, EDHF-mediated 
relaxation increases when the size of the vein decreases [Zhang et al, 2004 • 
1.3 Effect of ischemia-reperfusion on endothelial function 
in coronary circulation 
Although cardiac ischemia is usually characterized as a disease of the 
myocyte, it is clear that the vasculature, and especially endothelial cells, is also a 
major target of this pathology. The consequences of ischemia-reperfusion injury 
on myocytes have been studied intensely, and previous investigations of methods 
of myocardial protection during global and regional ischemia have focused on 
resultant alterations in myocardial function. However, only recently have 
investigators been able to assess coronary endothelial function. Evidence that 
myocardial ischemia leads to coronary endothelial dysfunction was first obtained 
by Ku who showed that a 90-min period of ischemia followed by 1-2-h reperfusion 
was associated with a decreased endothelium-dependent relaxation in response to 
thrombin in canine coronary arteries [Ku, 1982]. These findings were rapidly 
extended to other endothelium-dependent vasodilators such as ACh 
[VanBenthuysen et al, 1987]. The impaired endothelium-dependent responses 
were accompanied by marked structural injury to endothelial cells [assessed by 
electron microscopy]. However, the response to nitropmsside, an endothelium-
independent vasodilator, was intact. Endothelial dysfunction after reperfusion is 
not a transient phenomenon, since it persists for at least 4-6 weeks in experimental 
models [Kaeffer et al, 1996; Pearson et al, 1990]. However, while acute 
dysfunction is the consequence of structural injury to the endothelial cells, chronic 
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changes are rather a manifestation of dysfunctional regenerated endothelium 
Shimokawa et al, 1987]. 
With regard to the impact of ischemia-reperflision on individual relaxing 
factors, a large number of studies have been performed in the past years. Although 
there was evidence indicating decreased PGI2 synthesis [Watkins et al, 1995], a 
number of studies suggested that the NO transduction pathway is the dominant 
target of ischemia-reperfusion injury [Seccombe and Schaff, 1995; Engelman et al, 
1995; Tiefenbacher et al, 1996]. This point was supported by the altered 
endothelial and myocardial function with supplementation of NO precursors, NO 
donors, and NO synthesis inhibitors during the process of ischemia-reperfusion 
[Nakanishi et al, 1992; Lefer et al, 1993; Woolfson et al, 1995]. As to EDHF, the 
results of the effect of ischemia-reperfusion on the EDHF-mediated function are 
contradictory. In a rat model, A23187 and uridine 5-triphosphate induced, EDHF-
mediated relaxation of cerebral arteries was enhanced after 2-hour ischemia and 
24-hour reperflision [Marrelli et al, 1999; 2002]. Similar increase in the activity of 
EDHF was also observed in dog coronary arteries exposed to 1-hour ischemia 
followed by 2-hour reperfusion [Chan and Woodman, 1999]. On the other hand, in 
guinea pig basilar artery or in the porcine coronary arteries, EDHF-mediated 
responses were reduced by hypoxia [Petersson et al, 1998; Ren et al, 2002]. Those 
contradictory results may lead to the understanding that the alteration of EDHF-
mediated function in ischemia-reperfusion is due to complex mechanisms. 
1. 3.1 Ischemia-reperfusion injury 
Braunwald and Kloner characterized myocardial reperflision as “a double 
edged sword" [Braunwald and Kloner, 1985]. Indeed, although the benefit of early 
reperflision after acute myocardial ischemia is indisputable, reestablishment of 
coronary flow triggers a cascade of events that injures the coronary endothelium 
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and accelerates ischemically induced myocardial injury [Ku, 1982]. This 
phenomenon is termed as "ischemia-reperfusion injury" 
Multiple mechanisms are thought to play an important role in ischemia-
reperfusion injury in the heart: 
1) Impairment of vascular endothelium-dependent relaxation which causes 
edema formation due to the loss of barrier function. Damage to the coronary 
vascular endothelium begins within the first few moments of reperfusion and 
progresses with time [Tsao et al, 1990]. Interstitial and intracellular edema may 
cause extravascular compression of the coronary arteries and arterioles. Coronary 
artery smooth muscle damage may augment vascular tone and impair the 
relaxation. Impaired release of EDRFS may reduce coronary blood flow by 
increasing arterial tone. 
2) Activation of oxygen free radicals, which are strong promoters of 
neutrophil adhesion. Neutrophil activation and oxygen-derived free radicals have 
been implicated as major contributors to ischemia-reperfusion injury. It is 
becoming clear that reactive oxidant species, such as superoxide radicals and 
hydroxyl radicals, produced by cardiac cells, vascular endothelial cells, and 
neutrophils, are released within the first 3 min after reperfusion. In addition，these 
radicals are highly reactive and cause lipid peroxidation, protein oxidation, and 
DNA breakage [Thompson and Hess, 1986:. 
3) Enhancement of neutrophil and platelet aggregation and adherence to the 
endothelium, which causes inflammatory injury and a neutrophil-dependent 
increase in microvascular permeability, resulting in organ dysfunction. 
Neutrophils, activated during ischemia-reperfusion, release several toxic factors 
including oxygen radicals, proteases, elastases, and collagenases [Inauen et al, 
1990]. This cytotoxic milieu may damage endothelial cells and impair 
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physiological vasodilatory and antithrombotic mechanisms. In addition, it 
precipitates further increases in capillary permeability, stimulates platelet and 
neutrophil adhesion, and facilitates leukocyte infiltration of the myocardium. 
These changes create an environment within the vessels that is predisposed to 
thrombus formation, increased vascular tone, and ultimately, coronary vasospasm. 
4) Myocardial stunning, which is a regional post-ischemic mechanical 
dysftinction that persists after reperfusion. Myocardial stunning occurs despite the 
absence of irreversible myocyte damage, and despite the restoration of normal or 
near-normal coronary blood flow [Braunwald and Kloner, 1982]. It is associated 
with the depletion of adenosine triphosphate (ATP), but is not directly ameliorated 
by manipulations that increase ATP levels [Ambrosio et al, 1989]. The 
mechanisms that have been proposed include myocyte calcium overload and 
excitation-contraction uncoupling due to sarcoplasmic reticulum dysfunction 
[Bolli, 1990]. 
1.3.2 Effect of ischemia-reperfusion on endothelial function in 
coronary microarteries 
Ischemia-reperfusion is thought to be a major problem in open heart 
operations, including heart transplantation. With regard to ischemia-reperfiision 
injury, both myocytes and the coronary circulation may be affected. The layer 
impairment also includes the damage to the vascular smooth muscle and to the 
endothelium. The injury to myocytes may directly reduce cardiac contractility. 
The injury to the coronary circulation may change coronary vascular tone and 
resistance and, therefore, affect coronary flow during the reperfusion period. 
Reduction of coronary flow may damage myocardial perfusion and this, in addition 
to the ischemia-reperfusion injury to the myocardium, may further damage 
myocardial function. This functional change may cause mortality and morbidity in 
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cardiac surgery. Much has been done regarding the functional, histologic, and 
biochemical consequences of ischemia and reperfusion on the myocardium; here in 
the present study, we have examined the effects of ischemia and reperfusion on 
endothelial function in coronary microarteries. 
1.3.3 Effect of ischemia-reperfusion on endothelial function in 
cardiac veins 
The coronary venous system (cardiac veins) collects one-third blood of the 
coronary circulation and is considered to be an important site for the blood-tissue 
exchange of water and nutrients, as well as a possible determinant of ventricular 
distensibility [Watanabe et al., 1990]. It is suggested that coronary vein is an 
important component of resistance to coronary flow under conditions of arteriolar 
dilatation. Although the coronary venous system possesses 7% of total coronary 
vascular resistance in resting condition, its contribution greatly increases to 31% 
under vasodilated condition and it acts as a potential modulator of coronary blood 
flow [Chilian et al., 1989]. Thus, it has become a particularly important issue to 
investigate the regulatory role of the venous endothelial function with implications 
in cardiac surgery. 
It has been demonstrated that both NO and EDHF are involved in the 
regulation of the vascular tone in the coronary venous system although the amount 
of NO release and EDHF-mediated relaxation and associated hyperpolarization are 
less significant in the vein than in the artery [Zhang et al, 2004]. In the 
physiological condition, this weak endothelial function of the cardiac vein may be 
enough for the normal distribution of coronary blood flow. However, when the 
coronary venous system contributes a greater fraction of total coronary resistance 
under a pathological condition such as when the heart is subject to ischemia-
reperfusion injury, the endothelial response of cardiac veins may act as a more 
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important factor on the cardiac function. As well as coronary microarteries, in my 
study, we will examine the effects of ischemia and reperfusion on endothelial 
function in cardiac micro veins. 
1.4 Alteration of endothelial function during cardiac 
surgery 
The basic method in open-heart surgery is to arrest the heart under 
cardiopulmonary bypass (extracorporeal circulation) for precise intracardiac repair, 
coronary artery bypass grafting or transplantation. During cardiac arrest, the heart 
is inevitably subjected to ischemia and subsequent reperfusion injury and, 
therefore, myocardial function may be changed immediately after cardiac surgery. 
Ischemia-reperfusion injury is the major problem in open-heart operations, 
including heart transplantation. Since 1980s, it has become more and more clear 
that the ischemia-reperfusion injury is not only harmful to myocardium, but also to 
the coronary circulation [Hashimoto et al, 1991; Dignan et al, 1992; Ren et al, 
2001]. 
To protect the heart, cardioplegia and organ preservation solutions were 
developed to protect the myocardium by controlling the risk factors involved in 
ischemia-reperfusion injury [Follette et al, 1978; Jynge et al, 1978]. Because of 
differences between cardiac myocytes and vascular (endothelial and smooth 
muscle) cells in structure and function, these solutions may have an adverse effect 
on coronary vascular cells. However, such effect is often complicated by many 
other factors such as ischemia-reperfusion injury, temperatures, and perfusion 
duration. Therefore, to further protect the heart, supplemental therapy and 
optimizing the components of cardioplegia to restore the endothelial function may 
become more and more important. 
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1.4.1 Cardioplegia and organ preservation solutions 
Cardioplegia and organ preservation solutions were initially designed to 
protect the myocardium during cardiac operations and heart transplantation. 
Although the composition varies in different solutions, the pharmacological 
principles involved in myocardial protection are similar. First, immediate arrest 
induced either by K+, Mg2+, procaine, profound hypocalcemia or a combination of 
these modalities lowers energy demand to avoid depletion of the high-energy 
phosphate pool and conserve the myocardial energy reserves, which can be utilized 
during the period of ischemia to maintain ionic and metabolic homeostasis and 
consequently, leads to the better tolerance to ischemia. Second, reduction of 
myocardial temperature during arrest or storage lowers metabolic rate during 
ischemia. Third, supplementation of glucose and amino acid (i. e. glutamate or 
aspartate) enhances anaerobic or aerobic energy production (or both) with a buffer 
such as tris (hydroxymethyl) aminoethane, bicarbonate, phosphate, and histidine 
and optimizes stabilization provided by exogenous additives (i. e. steroids, 
procaine, oxygen radical scavengers, and Ca^^ antagonists), hypocalcemia or 
enrichment of Mg2+ may counteract the myocardial injury during ischemia and 
reperflision. Last, addition of osmotic agents such as mannitol and adjustment of 
inftision pressure will limit myocardial edema and prevent the occurrence of "no-
flow phenomenon" [Allen and Buckberg, 1999]. 
However, despite the protective effect on cardiac myocytes, more and more 
researchers found that those solutions may impair coronary vascular endothelial 
cells. To evaluate the effect of a solution on the coronary endothelial function, a 
number of points should be taken into consideration. First, in the whole heart, the 
overall effect of these solutions is a result of the combination of the effect on the 
cardiac myocytes and the coronary endothelial function. Second, the effect of the 
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solution on the individual EDRF must be distinguished. Third, the effect of each 
major component of the solution should be investigated. Lastly, the effect of a 
variety of new additives in the solution may be studied. ST cardioplegia is more 
often applied in cardiac surgery combined with mild to moderate systemic 
hypothermia and local hypothermia. Therefore, in my study, we concentrate on the 
study of the effect of ST solution on endothelial ftinction. 
St. Thomas Hospital (ST) solution 
ST solution is an extracellular type of solution that was first designed as 
crystalloid cardioplegia and widely used in the 1970s and the 1980s until blood 
cardioplegia became popular. The subsequent discovery of the efficacy of ST in 
heart storage promoted its application in the field of heart preservation for 
transplantation [Wheeldon et al, 1992; Demertzis et al, 1993]. The following is the 
different composition between Krebs and ST solutions. 
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Table.1.1 The composition of Krebs and ST solutions 
Composition Krebs ^ 
Na + (mmol/L) 143.4 138 
K+(mmol/L) 5.9 20 
Ca2+(mmol/L) 2.5 2.7 
Mg2+ (mmol/L) 1 • 2 16 
Cr (mmol/L) 128.7 ]_57 




Procaine (mmol/L) -- 1 
Glucose (mmol/L) 11. 1 ~ 
Pentafraction(g/L) ~ ~ 
Lactobionic acid 
一 一 一 — 
(g/L) 
Lactate (g/L) -- 28 
Raffinose (g/L) ~ ~ 
Adenosine (g/L) ~ ~ 
Allopurinol (g/L) - ~ 
Total glutathione 
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1.4.2 Combined effects of hypoxia-reoxygenation and ST solution 
on endothelial function in coronary microarteries/cardiac veins 
Hypoxia-reoxygenation injury remains the major cause of cardiac 
dysfunction in open heart surgery including heart transplantation. It is now widely 
recognized that the microvasculature, particularly the endothelial cells lining blood 
vessels, is very vulnerable to the deleterious consequences of ischemia and 
reperftision. Use of depolarizing cardioplegia (potassium at high concentrations, 
usually 10 to 20 mmol/L) is the most common method for myocardial preservation 
in open heart operations [Hearse, 1980]. During cardiac arrest, cardioplegia 
directly contacts the vascular endothelium. The effect of cardioplegia on 
endothelium is, therefore, another important aspect in myocardial protection 
[Nilsson et al, 1991; He et al, 1994; He et al, 1995]. In recent studies, our lab [He 
and Yang, 1996; He et al, 1996] has demonstrated that hyperkalemic solutions 
affect coronary endothelial function by reducing EDHF-mediated relaxation. The 
possible mechanism for this is through affecting K channels or direct 
depolarization of the membrane potential of the smooth muscle cell [He et al, 
1997]. However, the combined effects of H-R and cardioplegia solution, such as 
ST solution, on the EDHF-mediated endothelial function under clinically relevant 
temperatures remain unknown and therefore this became one of the aims of the 
present study. 
1.4.3 Effect of nicorandil on endothelial function 
Noma originally described KATP channels in guinea pig cardiac myocytes in 
1983 [Noma, 1983]. He proposed that these channels couple myocardial 
metabolism to membrane electrical activity and that this may provide a 
cardioprotective mechanism. Nicorandil is a hybrid compound which is the first 
clinically available KATP channel opener with a nitrate-like effect. Like nitrates, 
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nicorandil activates cytoplasmic guanylate cyclase, leading to an increase in 
cellular levels of cyclic guanosine monophosphate and a reduction in cytosolic 
calcium and thus, to a relaxation of vascular smooth muscles [Flaherty, 1989]. As 
a KATP channel opener, nicorandil increases efflux of potassium ions from the cell, 
leading to a more negative resting membrane potential (hyperpolarization), and 
also shortens the action potential duration. This inhibits calcium influx, causing a 
reduction in intracellular calcium and leading to relaxation of vascular smooth 
muscle and vasodilation (indirect calcium channel blocking effect) [Kukovetz et al, 
1991; Kukovetz et al, 1992]. Through this dual action, nicorandil reduces both 
preload (nitrate-like effect) and afterload (potassium channel opener effect), and 
improves coronary blood flow. A recent clinical study in coronary surgery by 
Hayashi and colleagues suggested that nicorandil administration during 
cardiopulmonary bypass provides enhanced myocardial protective effects against 
ischemia-reperfusion in patients undergoing coronary artery bypass grafting 
Hayashi et al, 2001]. Use of nicorandil also shows potent cardioprotective effect 
in rabbits [Tang et al, 2004]. When nicorandil is used as a component of ST 
solution [Steensmd et al, 2004] or blood cardioplegia [Steensrud et al, 2003], 
replacing potassium, it improves preservation of energetics and function in pig 
hearts. It has also been reported that when added in cold hyperkalemic solution, 
nicorandil is beneficial to the Indo and L-NNA-resistant endothelial function in the 
pig [Long et al, 2002]. 
Although previous studies have revealed the cardioprotective effect of 
nicorandil, it is unclear regarding the effect of nicorandil in cardioplegia or organ 
preservation solutions on the vascular endothelial function under H-R, in 
particular, the function mediated by EDHF. The work presented in this thesis 
demonstrated for the first time that in porcine coronary microarteries, nicorandil 
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preserves the EDHF-mediated relaxation and restores the EDHF function impaired 
by H-R. These findings help to better understand the influence of nicorandil-
containing cardioplegic solutions on the coronary circulation. 
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Chapter 2 
Materials and Methods 
2.1 Isometric force study in microarteries/ veins 
2.1.1 Preparation of vessels 
2.1.1.1 Preparation of porcine coronary microarteries 
Fresh porcine hearts collected from a local slaughterhouse were placed in a 
container filled with cold Krebs solution and immediately transferred to the 
laboratory. Upon receipt of the heart, intramyocardial coronary microarteries 
(usually the tertiary branches of the left anterior descending artery) with diameter 
of 200 to 450 |im were carefully dissected and removed under a microscope, with 
care taken to protect the endothelium. The vessels were cleaned of fat and 
connective tissue and cut into cylindrical rings of 2-mm length under a microscope. 
The whole dissecting process was performed in cold Krebs solution that was 
continuously aerated with a gas mixture of 95% O2 plus 5% CO2. The composition 
(in mM) of Krebs solution is: NaCl: 118. 4; KCl: 4. 7; MgSCX 7H20: 1. 2; 
K H 2 P O 4 ： 1. 2; NaHCOs: 25; (+)-Glucose: 11. 1; and CaCh. 2H2O: 2. 5. The final 
molar concentration (in mM) is: 143. 4 Na+, 5.9 K+, 2.5 Ca�.，1.2 Mg"., 128.7 CI", 
25 HCO3-, 1.2 SO42-, 1.2 H2PO4" and 11.1 glucose (Table 1.1). The temperature 
was maintained at 37±0. 1°C. 
2.1.1.2 Preparation of porcine cardiac veins 
The preparation of porcine cardiac veins follows the same procedure as in 
coronary microarteries. Upon receipt of the heart, the cardiac microveins (usually 
the adjacent vein to the tertiary branches of the left anterior descending artery) with 
diameter of 200 to 450 |im were carefully dissected. The vessels were cleaned of 
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fat and connective tissue and cut into cylindrical rings of 2-mm length under a 
microscope. 
^ ^ ^ , " ^ ; > ^ L e ， 。 r � _ r y artery 
/. / 亏 ^ V t Left marginal branch 
Diagonal brarieh 
Anterior inteTOntricufar / I 
b ra— 么 W 
Left anterior descending ^ ^ ^ 
Coronary micro artery 
Fig 2.1 Diagram indicating the anatomic location of porcine coronary 
microvessels used in the present study. Porcine coronary microarteries/veins were 
dissected from the tertiary branches of the left anterior descending artery/cardiac 
vein. 
38 
Chapter 2 Materials and Methods 
2.1.2 Technique of setting up 
2.1.2.1 Mounting of microvessels 
After the vessels were dissected and cut into 2-mm-length rings, they were 
mounted in a four-channel myograph (model 610M; J.P. Trading, Aarhus, 
Denmark) for isometric force study. In details, the ring was guided onto a suitable 
length of stainless steel wire (40 |Lim in diameter) through its lumen. The wire was 
fixed tightly on a jaw in the chamber of a four-channel myograph. Another wire 
was passed lightly through the lumen and then anchored to the other jaw of the 
same chamber. These two jaws were either attached to a force transducer or to a 
micrometer. An adjustable micrometer can pull the jaws apart and stretch the 
artery between the two parallel wires. A calibrated force transducer was used to 
measure the force of the vessel and the force trace was displayed on a computer 
with printed output. Data were digitized and stored in the computer. After the 
rings were mounted in the myograph, the Krebs solution in the chambers was 
continuously aerated with a gas mixture of 95% 02-5% CO2 at 37 士 0.1 
2.1.2.2 Normalization procedure for microvessels 
The microvessel rings were equilibrated at 37±0.1°C for more than 30 
minutes. The wires were pulled apart in steps every minute until the passive 
transmural pressure of the vessel reached 100 mm Hg (for coronary microarteries) 
or 30 mmHg (for coronary microveins). The computerized program fit the points 
to an exponential curve for each ring and calculated the optimal lumen diameter, 
which was estimated to be equivalent to 90% of the diameter at a passive 
transmural pressure of 100 mm Hg (for coronary microarteries) or 30 mmHg (for 
coronary microveins) [Mulvany, 1988; He et al, 1988]. The vessel was then 
released to the normalized value and the transmural pressure at this diameter was 
maintained throughout the experiments. The isometric force at this setting is the 
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“passive” or “resting” force in the absence of constricting tone. This method 
allows the vessel in vitro set at a physiological pressure that has been shown to 
allow maximum force generation. 
2.1.3 EDHF-mediated vasorelaxation 
2.1.3.1 Precontraction and stimuli of EDHF 
From a number of vasoconstrictors, U46619 was selected to precontract the 
vessels in this study. As a thromboxane A2 mimic, U46619 contracts the smooth 
muscle by acting on thromboxane A2 receptor and stimulating the influx of 
2+ 
extracellular Ca^^ in smooth muscle cells via both L-type and non L-type Ca 
channels. In addition, a Ca^^ elevation-independent mechanism is also involved in 
the U466i9-induced contraction [Tosun et al, 1998]. The dose of U46619 usually used 
in coronary vessels was 10-100 nM, based on previous pilot experiments. 
The most commonly used EDHF stimuli include ACh, SP, and BK, which 
exert their effects through receptors-dependent pathways. In this study, BK was 
used to stimulate the production of EDHF. Through interacting with B2 receptors 
2+ 
on the endothelial cells, BK increases the level of intracellular free Ca via the 
receptor-coupled G proteins, resulting in the release of a variety of vasoactive 
substances including EDHF [Baydoun & Woodward, 1991; Graier et al, 1992；. 
2.1.3.2 “True，，response of EDHF 
Since the proposal of EDHF in vascular system, the routine way to study 
this factor distinct from NO is to inhibit the effect of PGI2 and NO with COX and 
NOS inhibitors. However, there is evidence indicating that NOS inhibitors cannot 
completely block the production of NO even at high concentrations and that the 
residual NO accounts fully for endothelium-dependent relaxation and 
hyperpolarization of the rabbit carotid artery [Cohen et al, 1997]. In Simonsen's 
study, with the presence of NOS inhibitor L-NNA , additional application of HbO, a 
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NO scavenger, could block the vasorelaxation and NO increase induced by ACh, 
S-nitroso-N-acetylpenicillamine (SNAP) and S-morpholino-sydnonimine (SIN-1) 
in rat superior mesenteric arteries and HbO is also demonstrated to be effective in 
decreasing the NO concentration below baseline level [Simonsen et al, 1999'. 
The work from our own laboratory fully supported the use of HbO in 
eliminating the effect of residual NO during the investigation of EDHF-related 
function. By directly measuring the NO concentration with a NO-specific 
electrode, we demonstrated that in porcine coronary arteries, NO release of 
endothelial cells was stimulated by BK from 9.3±1.7 to 166.7±18.3 nM; L - N N A 
significantly reduced NO concentration to 49.3±7.8 nM that was finally abolished 
by HbO [Yang et al, 2003a]. 
Based on all of these studies, the combination of NOS inhibitor and NO 
scavenger to eliminate the effect of NO is essential for revelation of the "true 
response of EDHF" in endothelium-dependent vascular relaxation and 
hyperpolarization. This principle was followed in the experimental design in this 
study. 
2.1.4 Data acquisition and analysis 
Data acquisition and data analysis were respectively performed by Myodaq 
acquisition Version 2.01 and Myodata analysis Version 2.02 provided along with 
the myograph system. 
2.2 Hypoxia and reoxygenation 
PO2 was measured by an Oxygen Meter (Model 781; Strathkelvin 
Instrument, Glasgow, Scotland, UK). 
2.2.1 Calibration of Oi-special electrode 
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The oxygen electrode consists of a probe at whose tip is an exposed 
platinum cathode and a silver chloride anode. When the anode and cathode are 
polarized so that the cathode is held at a voltage of -0.6 to -0.8 volts relative to the 
anode and connected by a solution of electrolyte such as KCL, the following 
reaction will occur at the anode: 
4Ag • 4Ag+ + 4e and 4Ag+ + 4Cr • 4AgCl 
Simultaneously, at the cathode any oxygen that is present is reduced: 
02+2H20 + 4e MOH-
Thus for each oxygen molecule reduced, 4 electrons of current flow in the 
circuit. Oxygen is therefore continually consumed as it is reduced to OH" at the 
cathode. In practice, the anode and the cathode are covered by an oxygen 
permeable membrane to exclude other species which would interfere. The KCl 
electrolyte is buffered to remove the OH" produced in the cathode reaction. 
The electrode needs to be calibrated at zero oxygen and at a higher point. 
The higher calibration should be made at the start of each day, while zero 
calibration need only be carried out once a week. We used crystalline sodium 
sulphite for zero calibration and a fully air saturated solution for high point 
calibration. 
2.2.2 Measurement of O2 
During normalization or relaxation studies, the solution was aerated with a 
gas mixture of 95% O2 and 5% CO2. Hypoxic condition was induced by switching 
bubbling gas from 95% O2 and 5% CO2 to 95% N2 and 5% CO2 in the plastic 
cover-sealed chamber. During the period of hypoxia, the tip of the electrode was 
inserted vertically into the solution and the measurement of O2 was performed. 
2.3 Statistical analysis 
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Relaxation was expressed as the percentage decrease in isometric force 
induced by U46619. The effective concentration of BK that caused 50% of maximal 
relaxation was defined as E C 5 0 . The E C 5 0 was determined from each 
concentration-relaxation curve by a logistic, curve-fitting equation: E = MA^/ (A^ 
+ K^), where E is response, M is maximal relaxation, A is concentration, K is E C 5 0 
concentration, and P is the slope parameter. From this fitted equation, the mean 
EC50 士 SEM was calculated for each group. 
Data were expressed as mean 士 SEM. Different statistical analyses were 
used in different conditions including paired, unpaired t-test and one-way ANOVA 
(followed by Scheffe F test). Values of p less than 0.05 were considered 
significant. 
2.4 Chemicals 
Drugs used and their sources are as follows: BK, L - N N A , Indo, HbO 
(Sigma, St. Louis, MO, USA); nicorandil (Fujigotemba Research Laboratories, 
Chugai Pharmaceutical Co., Ltd., Komakado l-t35, Gotemba 412, Japan), and 
U46619 (Cayman Chemical, Ann Arbor, MI); L - N N A (dissolved in distilled water) 
and Indo (dissolved in ethanol) were stored at 4°C. The solution of U46619 was held 
frozen until required. HbO, nicorandil, and BK were held frozen until needed. 
The ST was purchased from David Bull Laboratories, Mulgrave, Victoria, 
Australia. Commercial bovine hemoglobin was dissolved in 0.9% NaCl to make 
up a 3 ml stock solution. The stock solution was subsequently reduced to HbO by 
addition of a small amount of sodium dithionite (< 0.3 g). Excessive sodium 
dithionite was extracted by running the solution through an Econo-Pac lOG 
column (Bio-Rad) equilibrated with 0.9% NaCl. The HbO solution was frozen at -
20°C and stored for up to 14 days [Martin et al, 1986；. 
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Chapter 3 
Hypoxia-Reoxygenation in Coronary Microarteries: 
Combined Effect with St Thomas Cardioplegia and 
Temperature on the Endothelium-derived 
Hyperpolarizing Factor and Protective Effect of 
Nicorandil 
3.1 Abstract 
Objective We investigated the effects of H-R with or without ST solution under 
clinically relevant temperatures and the possible protective effect of nicorandil on 
EDHF-mediated relaxation in porcine coronary microarteries. 
Methods Porcine coronary microarteries (diameter 200 to 450 |im) were 
normalized in a myograph and subjected to hypoxia (P02<5mmHg) for 30 minutes 
in Krebs at 37°C, or for 60 minutes in Krebs and ST with or without nicorandil 
(0.1 [xM) at 37�C or 4�C, followed by 30-min-reoxygenation. The EDHF-
mediated relaxation by BK (-10—6 logM) was studied in the U466i9-precontraction 
in the presence of Indo (7 ^iM), L - N N A (300 |iM), and HbO (20 ^iM). 
Results The maximal EDHF-mediated relaxation was significantly reduced after 
hypoxia for 30 minutes (59.9% ±1.6 % vs. 81.2 %±3.5 % , p < 0.05) or 60 minutes 
(44.4% 士 6.0O/O vs. 82.7% 士 7.4o/o, p < 0.001) in Krebs or ST (28.9% 士 1.8o/o vs. 
78.1% 士 3 . 0 % , < 0.001) at 37°C and at 4°C (Krebs: 49.3% 士 3.0o/o,;? < 0.001; ST: 
43.1% 士 2.6o/o, J? < 0.001) but there were no significant differences between Krebs 
and ST (p> 0.05). Further, the relaxation was significantly less after exposure to 
ST at 37°C than at 4°C (p < 0.001). The reduced relaxation during prolonged H-R 
in Krebs or ST at different temperatures was recovered by addition of nicorandil 
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(Krebs at 37°C: 8 1 . 7 ± 3 . 4 % , < 0.001; ST at 37°C: 71.0±7.9%,<0.001; ST at 
4 � C : 85.3±3.3%,；7< 0.001) 
Conclusions We conclude that 1) H-R impairs EDHF-mediated relaxation in the 
coronary microarteries and the injury is more severe during prolonged H-R; 2) ST 
does not provide protection to the EDHF-mediated relaxation impaired by H-R 
although its detrimental effect at 37�C is eliminated at 4°C; 3) As an additive to 
Krebs or ST during hypoxia under normothermia or profound hypothermia, 
nicorandil may fully restore EDHF-mediated endothelial flinction after prolonged 
H-R. This study reveals the change of the EDHF-mediated relaxation due to H-R 
and supports the use of nicorandil as an additive in cardioplegia to protect the 
coronary endothelial function. 
3.2 Introduction 
Ischemia-reperfusion injury remains the major cause of cardiac dysfunction 
in open heart surgery including heart transplantation. Cardioplegia was designed 
to protect the heart from ischemia-reperfusion injury. Although blood cardioplegia 
is popular in current cardiac surgery, ST cardioplegia is still used either as 
crystalloid cardioplegia or the basis of blood cardioplegia in combination with 
hypothermia or normothermia. ST solution has also been used in donor heart 
preservation under hypothermia for transplantation and has been demonstrated to 
be effective in protecting the myocardium against ischemia [Demertzis et al, 1993 • 
Hyperkalemia (potassium at high concentration), as the key component, 
contributes to cardiac protection by depolarizing the myocyte membrane and 
causing asystole, which avoids the depletion of the high-energy phosphate pool by 
ischemia and conserves the myocardial energy reserves [Allen and Buckberg, 
1999]. However, studies also showed that cardioplegia damages coronary 
endothelial function [Mankad et al, 1991; Sellke et al, 1993]. Our previous studies 
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further demonstrated that in both large and microcoronary arteries, EDHF-
mediated function is impaired by hyperkalemic solutions such as ST [He et al, 
1996; He, 1997; Ge and He, 1999; Yang et al, 2003]. 
H-R (or ischemia-reperfusion) injury involves damage to myocytes as well 
as the coronary circulation (the vascular smooth muscle and the endothelium). In 
the past, the myocyte injury has been extensively studied. However, only in recent 
years have studies been focused on H-R injury to coronary circulation [Maczewski 
and Beresewicz, 1998; Ren et al, 2001]. It has been demonstrated that both NO 
[Hein et al, 2003; Lefer, 1995], and EDHF [Liu and Flavahan, 1997; Ren et al, 
2002] -mediated relaxations may be affected by H-R injury in coronary arteries. 
Endothelium plays an important role in regulating the activity of the 
underlying vascular smooth muscle. Endothelium-dependent relaxation is known 
to be due to a variety of different endothelium-derived relaxing factors. These 
include NO [Ignarro et al, 1987; Palmer et al, 1987], FGh [Moncada and Vane, 
1978], and EDHF. The nature of EDHF has not been identified [Cohen and 
Vanhoutte, 1995; Feletou and Vanhoutte, 2000; Vanhoutte, 1998], although EETs 
Yang et al, 2003], anandamide, the potassium ion, H2O2, citmlline, NHS, and 
nucleotides (ATP) [Vanhoutte, 1998] have been suggested to be EDHF. It has 
been demonstrated that EDHF plays a role in blood flow homoeostasis in both 
conduit and resistance arteries under the physiological states, and may be a crucial 
compensatory or reserve mechanism for the maintenance of nutritive organ blood 
flow after inhibition or impairment of the NO/PGI2 pathway, particularly in the 
coronary microarteries [Feletou and Vanhoutte, 2000; Vanhoutte, 1998]. 
A large number of studies have shown that EDHF induces vascular smooth 
muscle relaxation via hyperpolarization of the smooth muscle cell [Cohen and 
Vanhoutte, 1995; Feletou and Vanhoutte, 2000], which may involve potassium (K+) 
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channels particularly KCa channels [Marrelli et al, 2003; Gschwend et al, 2003；. 
KATP channel is expressed in vascular smooth muscle and endothelial cells. 
Nicorandil, a hybrid compound of KATP channel opener and a NO donor, has been 
reported to preserve microvascular integrity in patients with reperflised myocardial 
infarction [Markham et al, 2000] and it has been shown to be beneficial to the 
coronary function from our laboratory [Yang et al, 2005]. However, it remains 
unknown whether it has the protective effect on the EDHF-mediated function in 
coronary microarteries under H-R. Further, the effect of nicorandil as an additive 
to ST on EDHF-mediated function under H-R has not been studied yet. 
Taken together, during open heart surgery, the coronary endothelium may 
be damaged by both ischemia-reperfusion and cardioplegia. Subsequently, this 
may affect cardiac function immediately after cardiac surgery and cause mortality 
or morbidity. Since the coronary microvascular system plays the key role in the 
regulation of myocardial perfusion, the investigation on the combined effects of 
cardioplegia and H-R on the endothelial function in the coronary microvascular 
system is particularly important. In addition, temperature is another factor that 
may also affect the endothelial function. 
The present study was therefore designed to examine the effects of H-R 
with or without ST under normothermia or hypothermia and the possible protective 
effect of nicorandil on EDHF-mediated relaxation in porcine coronary 
microarteries. 
3.3 Experimental design and analysis 
3.3.1 Vessel Preparation 
Upon receipt of the heart, intramyocardial coronary microarteries (usually 
the tertiary branches of the left anterior descending artery) in diameter of 200 to 
450 |a,m were carefully dissected and cut into cylindrical rings of 2-mm length 
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under a microscope. The rings were then set up in a 4-channel myograph (Model 
610M; J. P. Trading, Aarhus, Denmark) as described in Gereral Methods (See 
Chapter 2.1). 
3.3.2 Normalization 
The ring was guided onto suitable lengths of two stainless steel wires (40 
jLiM in diameter) through its lumen, and fixed tightly in a 4-channel myograph 
(Model 610M; J. P. Trading, Aarhus, Denmark). After the normalization described 
in Gereral Methods (See Chapter 2. 1), the computerized program determines the 
length-tension exponential curve for each ring and gives the internal circumference 
and diameter at a pressure of 100 mmHg. The internal circumference was then set 
to the value, estimated to be equivalent to 90% of the circumference at a passive 
transmural pressure of lOOmmHg. This pressure was maintained throughout the 
experiments. 
3.3.3 Hypoxia 
During normalization or relaxation studies, the solution was aerated with a 
gas mixture of 95% O2 and 5% CO2 (normoxia, the partial pressure of oxygen [PO2: 
was more than 200 mmHg). Hypoxic condition was induced by switching 
bubbling gas from 95% O2 and 5% CO2 to 95% N2 and 5% CO2 (hypoxia, P02< 
5mmHg) in the plastic cover-sealed chamber. PO2 was measured by an Oxygen 
Meter (Model 781; Strathkelvin Instrument, Glasgow, Scotland, UK) as described 
in General Methods (see Chapter 2.1). 
Protocol 
All rings were equilibrated for at least 30 minutes before and after 
normalization. The following protocol was used. 
48 
Chapter 3 H-R, ST nicorandil & EDHF in CA 
3.3.4 Effect of H-R on EDHF-mediated relaxation in coronary 
microarteries 
Twelve coronary microarterial rings were allocated into two groups (n=6). 
One group of rings was incubated in Krebs solution at 37°C and subjected to 
hypoxia (P02<5mmHg) for 30 minutes followed by 30-minute-reoxygenation 
(Group lA). The other was incubated in Krebs solution at 37°C and subjected to 
hypoxia (P02<5mmHg) for 60 minutes followed by 30-minute-reoxygenation 
(Group IB). Before (as the control) and after H-R, The artery was precontracted 
with U46619 (-8 logM) and EDHF-mediated relaxation was induced by BK (-10— 
6 log M) in the presence of Indo (7 L A M ) , L - N N A (300 jiM), and HbO (20 |iM) to 
eliminate the effect of NO and P G I 2 . 
3.3.5 Combined effects of H-R and ST solution on EDHF-mediated 
relaxation in coronary microarteries 
The rings were incubated in Krebs solution (as the control) at 37�C for 30-
min and the EDHF-mediated relaxation was induced by BK. The rings were 
washed with Krebs solution and then incubated in ST at 37�C, subjected to 
hypoxia for 60-min followed by 3 0-min-reoxygenation (n=6). The EDHF-
mediated relaxation was then induced by BK again (Group IIA). 
Two rings from the same microartery were allocated into two groups. One 
was incubated in ST and the other in Krebs (as the control) at 4 � C for 60-min-
hypoxia, followed by 30-min-reoxygenation. The EDHF-mediated relaxation to 
BK was established. (Group IIB). 
3.3.6 Effect of addition of nicorandil to Krebs or ST solution under 
H-R on EDHF-mediated relaxation in coronary microarteries 
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The rings were incubated in Krebs solution with addition of nicorandil (0.1 
jiM) at 37°C and subjected to hypoxia for 60-min followed by 30-min-
reoxygenation (n二6). Before (as the control) and after H-R, the EDHF-mediated 
relaxation to BK was induced (Group III A). 
The rings were incubated in Krebs solution (control) at 37°C for 30-min 
and the EDHF-mediated relaxation to BK was induced. The rings were then 
washed with Krebs solution and subjected to 60-min hypoxia with nicorandil (0.1 
ILIM) added into ST, followed by 30-min-reoxygenation (n=6). The EDHF-
mediated relaxation was induced by BK again (Group IIIB). 
The protocol was similar as the above, except that the microarteries were 
incubated in nicorandil added ST at 4 � C (Group IIIC). 
33.7 Data analysis 
Relaxation was expressed as the percentage decrease in isometric force 
induced by U46619. Data are expressed as mean 士 SEM for n observations, where n 
equals the number of coronary vessel rings. One-way ANOVA followed by the 
Scheffe F test, paired t test or unpaired t-test was used to calculate the difference. 
P<0.05 was considered to be statistically significant. The effective concentration 
of bradykinin that caused 50% of maximal relaxation was defined as the E C 5 0 . The 
E C 5 0 was determined from each concentration-relaxation curve by a logistic, 
curve-fitting equation: E = MA?/ (A? + K^), where E is response, M is maximal 
relaxation, A is concentration, K is E C 5 0 , and P is the slope parameter. From this 
fitted equation, the mean E C 5 0 士 SEM was calculated for each group. 
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3.4 Results 
3.4.1 Resting force 
H-R did not significantly alter the resting force in the arteries incubated 
with Krebs and ST solution with or without nicorandil either at 37�C or at 4 � C {p > 
0.05, Table 3.1). 
3.4.2 U46619-induced contraction force 
The concentration of U46619 varied from -8 logM to -7 logM to maintain a 
similar stable contraction force between the control and H-R condition in each 
group (p>0.05, Table 3.2). 
3.4.3 Partial pressure of oxygen in hypoxia 
The normal PO2 (>200mmHg) was quickly lowered to 30 mmHg in 5 min 
and further lowered to less than 5 mmHg in another 10 min and maintained a low 
level throughout the experiment. In 30-min-hypoxia group, the PO2 was 4.6 士 0.3 
mmHg and in 60-min-hypoxia group, it was 2.7 士 0.2 mmHg. (Fig 3.1) 
3.4.4 EDHF-mediated relaxation in coronary microarteries 
3.4.4.1 Effect of H-R 
Exposure to hypoxia for 30 minutes or 60 minutes in Krebs solution at 
37°C followed by 30-min reoxygenation significantly decreased the EDHF-
mediated relaxation. The maximal relaxation was reduced from 81.2% 士 3.5% in 
control to 59.9% 士 1.6o/o in 30-min-hypoxia group (p < 0.05, 95% CI: 8.9% to 
33.7%; Fig 3.2a, Fig 3.3a) and from 82.7% 士 7.4o/o to 44.4% 士 6.0o/o in 60-min-
hypoxia group {p = 0.000, 95% CI: 29.0% to 47.7%; Fig 3.2b, Fig 3.3b). Further, 
the reduction of the relaxation was more severe during prolonged H-R (44.4% 士 
6.0% vs. 59.9% 士 1.60/0,;? = 0.03, 95% CI: -29.3% to -1.73%). 
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With regard to the E C 5 0 , there were no differences between the groups. It 
was -8.08 士 0.31 log M in the control group compared with -7.92 ± 0.18 log M (p 
=0.43, 95% CI: -0.66 to 0.33 log M) in the 30-min-hypoxia group. And it was -
8.11 士 0.27 log M in the control group compared with -7.83 士 0.17 log M (/? = 0.31, 
95% CI: -0.91 to 0. 6 log M) in the 60-min-hypoxia group. 
3.4.4.2 Combined effects of H-R and ST solution on EDHF-mediated 
relaxation 
Exposure to ST solution at 37°C for 60-min-hypoxia significantly 
decreased EDHF-mediated relaxation from 78.1% ±3. 0% to 28.9% 士 1.8o/o (p = 
0.000, 95% CI: 40.2% to 58.4%, Fig 3. 4a, Fig 3. 5a) with unchanged EC50 (-8.07 
±0.18 vs. -8.07 士 0.22 log M in the control group, p =0.95, 95% CI: -0.26 to 0.27 
log M). Comparing ST with Krebs solution, the relaxation was significantly less 
after exposure to ST (28.9% 士 1.8o/o vs. 44.4% 士 6.0o/o,;?=0.03, 95% CI: -29.4% to 
-1.6%). 
Hypoxia for 60-min in Krebs (49.3% 士 3.0o/o, ；7<0.001) or ST (43.1% 士 
2.6%, ；?<0.001) at 4 � C also reduced the EDHF-mediated relaxation although there 
were no significant differences between Krebs and ST regarding relaxation {p = 
0.14, Fig 3. 4b, Fig 3. 5b) or E C 5 0 (-7.60 士 0.09 vs. -7.8 士 0.18 log M in the control 
group, p = 0.32, 95% CI: -0.24 to 0.66 log M). Further, the relaxation was 
significantly less after exposure to ST at 37°C than that at 4°C (p = 0.001，95% CI: 
-21.25% to -7.12%). 
3.4.4.3 Effects of addition of nicorandil to Krebs or ST solution under H-R on 
EDHF-mediated relaxation 
Addition of nicorandil to Krebs solution at 37°C, or to ST solution at 37°C 
or 4 � C for 60-minute hypoxia significantly increased the EDHF-mediated 
relaxation. The maximal relaxation in Krebs at 37°C was 81.7% 士 3.4o/o, 
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compared to 44.4% 士 6.0o/o in the arteries exposed to Krebs without nicorandil for 
60-min-hypoxia (p = 0.000, 95% CI: 22.1% to 52.6%, Fig 3.6a, Fig 3.7a). 
Similarly, the reduced EDHF-mediated relaxation by exposure to ST solution at 
37�C or 4°C for 60-min-hypoxia was also significantly increased by the addition of 
nicorandil (ST at 37°C: 78.5% 士 4.0o/o vs. 28.9% 士 1.8o/o, p = 0.000, 95% CI: 
39.8% to 59.4%, Fig 3.6b, Fig3.7b; ST at 4�C: 85.3% 士 3.3% vs. 43.1% 士 2.6o/o,;7 
=0.000, 95% CI: 32.9% to 51.6%, Fig 3.6c, Fig3.7c). 
Addition of nicorandil in Krebs at 37�C or in ST solution at 37�C or 4°C 
for 60-min-hypoxia did not alter the E C 5 0 . It was —7.91 士 0.08 vs. -7.83 士 0.17 log 
M in nicorandil-added Krebs group {p = 0.68, 95% CI: —0.49 to 0.33 log M) and 
-7.64 ±0.11 vs. -8.07 ± 0.18 log M in the ST at 37°C {p = 0.07, 95% CI: —0.04 to 
0.90 log M) and -7.58 ± 0 07 vs. -7.60 士 0.09 log M (p = 0.86, 95% CI: -0.23 to 
0.27 log M) in the ST at 4�C. 
3.5 Discussion 
The present study for the first time demonstrates in porcine coronary 
microarteries that (l)H-R impairs EDHF-mediated relaxation in the coronary 
microarteries and the injury is more severe during prolonged H-R; (2) under the 
condition of either profound hypothermia (4�C) or normothermia (37°C), ST does 
not provide protection to the EDHF-mediated relaxation impaired by H-R although 
its detrimental effect at 37°C is eliminated at 4°C; and 3) as an additive to Krebs or 
ST during hypoxia under normothermia or profound hypothermia, the potassium 
channel opener nicorandil may restore EDHF-mediated endothelial function and 
therefore this study supports the use of nicorandil as an additive in cardioplegia to 
protect the coronary endothelial function. 
3.5.1 EDHF-mediated relaxation after exposure to H-R 
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The cardiovascular diseases that are initiated by local or systemic tissue 
ischemia remain the chief cause of death in the world [Donna et al, 2000 . 
Reperfusion, the restoration of blood flow after a period of ischemia, can place 
ischemia organs at risk of further cellular necrosis and thereby limit the recovery of 
function. It is widely recognized that the microvasculature is very vulnerable to 
the deleterious consequences of ischemia and reperfusion. Evidence that 90-min 
period of ischemia followed by 1-hour reperfusion leads to coronary endothelial 
dysfunction was first obtained by Ku [Ku, 1982]. Later studies found that NO-
mediated relaxation was impaired by H-R [Donna et al, 2000]. Although the effect 
of H-R on membrane hyperpolarization has been studied [Siegel et al, 1992], there 
were few reports on the effect of H-R on EDHF-mediated relaxation [Ren et al, 
2001]. 
In the present study, EDHF-mediated (L-NNA , HbO, and Indo-resistant) 
relaxation was significantly reduced after H-R for 30-min and it was more severe 
after 60-minute hypoxia followed by 30-minute reoxygenation. Interestingly, the 
U46619-induced contraction was slightly affected by H-R. To fairly compare the 
relaxation, a similar precontraction force was essential and this was achieved in the 
present study by adding a higher concentration of U46619 (between 10-100 nM) 
after H-R to reach a similar precontraction (Table 3. 2). 
3.5.2 EDHF-mediated relaxation after H-R in ST at different 
temperatures 
The extracellular type of preservation solution ST was initially designed to 
eliminate the H-R injury of myocardium and has been demonstrated to be effective 
in cardiac protection. However, recent studies have provided evidence of the 
impairment of this solution on the endothelial function [He et al, 1996; Amrani et 
al, 1992]. The combined effect of H-R and ST on the EDHF-related endothelial 
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function under clinically relevant temperatures remains unknown. The present 
study indicates that exposure to ST solution under 60-minute hypoxia at 4 � C or at 
37°C reduced EDHF-mediated relaxation and therefore ST does not provide 
protection to the EDHF-mediated relaxation impaired by H-R although its 
detrimental effect at 37°C is eliminated at 4°C. 
With regard to the mechanism of reduced EDHF-mediated relaxation after 
exposure to ST during H-R, it is most likely related to the high K+ concentration 
(the potassium (K+) concentration is 20 mM) that reduces the EDHF-mediated 
relaxation by affecting K+ channels and prolonging the membrane depolarization 
[He et al, 1996; He et al, 1997] or preconditioning [Ren et al, 2002]. As shown in 
the present study, H-R damages EDHF-mediated function and this damage can not 
been eliminated by ST. 
3.5.3 Effect of addition of nicorandil to Krebs or ST Solution 
during H-R on EDHF-mediated Relaxation 
Over the years, there have been numerous modifications to the composition 
of cardioplegic solution. As a KATP channel opener, nicorandil has been 
demonstrated effective in myocardial protection against ischemia-reperfiision 
Markham et al, 2000]. When nicorandil is used as a component of ST [Steensrud 
et al, 2004] or blood cardioplegia [Steensrud et al, 2003], it improves preservation 
of energetics and fiinction in pig hearts and when added in hyperkalemic solution 
is beneficial to the Indo andL-NNA -resistant endothelial function in the pig [Long 
et al, 2002]. Nicorandil is the only K+ channel opener used clinically as 
cardioplegia to protect the myocardial function and a recent clinical study in 
coronary surgery by Hayashi and colleagues [Hayashi et al, 2001] suggests that 
nicorandil administration during cardiopulmonary bypass provides enhanced 
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myocardial protective effects against ischemia-reperfusion in patients undergoing 
coronary artery bypass grafting. 
Our data demonstrated that addition of nicorandil to Krebs or ST solution at 
different temperatures under H-R may restore the EDHF-mediated relaxation in 
coronary microarteries. With regard to the mechanism of the protective effect of 
nicorandil, it is most likely related to its effect to open K+ channels and therefore 
compensates or is synergetic to the mechanism of EDHF-mediated smooth muscle 
relaxation. 
3.5.4 Clinical Implications 
During cardiac surgery, the heart is inevitably subjected to ischemia and 
subsequent reperfusion injury. Hyperkalemic solutions are commonly used in 
cardiac surgery to protect the heart in order to produce better postoperative 
recovery of myocardial function. The perfect heart protection should include the 
preservation of cardiac myocytes as well as endothelium. Furthermore, perfect 
preservation of the endothelial function should involve all three EDRFs. The 
present study indicates that under the normothermic and hypothermic condition, 
addition of nicorandil to ST solution under H-R may restore the EDHF-mediated 
relaxation. The recovery of EDHF function in nicorandil-containing ST solution 
supports the use of nicorandil as an additive to ST cardioplegia to preserve the 
endothelial cell function in order to improve the performance of hearts subjected to 
global myocardial ischemia during cardiac surgery. The protective effect of 
nicorandil from this study provides new insights into the further development of 
cardioplegia and organ preservation solutions. 
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Table 3.1 Resting Force in Porcine Coronary Microarteries 
Resting force [mN] 
Group Control H-R p 95%CI 
lA 3.6 ±0.3 3.5 ±0.4 .4 -0.2�0.3 
IB 3.9 ±0.4 3.9 ±0.4 .6 -0.1�0.1 
IIA 2.9 士 0.3 2.9 士 0.3 .7 -0.3-0.2 
IIB 3.7 士 0.5 2/7 ±0.2 .1 -2.2-0.2 
III人 2.3 ±0.3 2.1 ±0.3 .2 -0.1 � 0 . 5 
IIIB 1.7 ±0.3 2.1 ±0.2 .5 -1.3-0.7 
IIIC 1.6 ±0.1 2.1 ±0.2 .1 -1.0�0.1 
Values are mean 士 SEM. Group I, Effect of H-R on resting force in microarteries; 
group lA: 30-min hypoxia in Krebs solution at 37°C; group IB: 60-min hypoxia in 
Krebs solution at 37�C. Group II, Effect of H-R and ST solution on resting force 
in microarteries; group IIA: 60-min hypoxia in ST at 37°C; group IIB: 60-min 
hypoxia in ST at 4�C. Group III, Effect of nicorandil on resting force in 
microarteries; group IIIA: 60-min hypoxia with nicorandil added into Krebs at 
37°C; group IIIB: 60-min hypoxia with nicorandil added into ST at 37°C; group 
IIIC: 60-min hypoxia with nicorandil added into ST at 4�C. The p values between 
paired groups were calculated with paired t test. CI = confidence interval. 
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Table 3. 2 U46619-induced contraction before and after H-R in each group. 
U46619 Contraction (mN) U46619 Concentration (Log M) 
Group Control H-R p 95%CI Control H-R p 95%CI 
lA 12.23 土 2.92 13.37 ±3.60 0.406 -4.38 � 2 . 0 9 -8.00 土 0.00 -7.74 土 0.07 0.013 -0.44 � - 0 . 0 9 
IB 12.50 ±4.39 12.50 士 4.24 0.994 -1.03 � 1 . 0 4 -7.93 士 0.04 -7.69 ± 0.04 0.001 -0.33 ~-0.16 
IIA 7.63 ±0.81 7.67 ± 1.03 0.973 -2.68 � 2 . 6 0 -7.89 士 0.07 -7.34 士 0.16 0.030 -1.02 � - 0 . 0 8 
IIB 9.51± 1.28 11.70土2.37 0.438 -8 .20�3 .83 -7.64±0.06 -7.55 士0.12 0.526 -0.22 ~ -0.40 
IIIA 13.22 士 2.35 12.15 土 2.34 0.350 -1.60 � 3 . 7 4 -7.88 ±0.05 -7.54 ±0.10 0.028 -0.40~0.12 
IIIB 13.94 ±1.96 15.57 ±2.87 0.248 -4.82- 1.57 -7.92 ±0.08 -7.37 ±0.10 0.004 -0.92�0.30 
IIIC 12.52 土 2.24 12.74±2.78 0.805 -2.37- 1.94 -8.00±0.00 -7.74 土 0.06 0.008 -0.42 � 0 . 1 0 
Values are mean 士 SEM. Group I, Effect of H-R on U466i9-medated contraction in 
microarteries; group lA: 30-min hypoxia in Krebs solution at 37°C; group IB: 60-
min hypoxia in Krebs solution at 37°C. Group II, Effect of H-R and ST solution 
on U466i9-medated contraction in microarteries; group IIA: 60-min hypoxia in ST 
at 37�C; group IIB: 60-min hypoxia in ST at 4�C. Group III，Effect of nicorandil 
on U466i9-medated contraction in microarteries; group IIIA: 60-min hypoxia with 
nicorandil added into Krebs at 37°C; group IIIB: 60-min hypoxia with nicorandil 
added into ST at 37°C; group IIIC: 60-min hypoxia with nicorandil added into ST 
at 4°C. The p values between paired groups were calculated with paired t test. CI 
=confidence interval. 
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Fig 3.1 Partial pressure of oxygen in hypoxia. Data are shown as mean 士 SEM. 
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Fig 3.2 Concentration-relaxation curves for bradykinin in the U46619 (10 nM)-
precontracted microarteries (see protocol) with the presence of Indo (7 |iM), L-
NNA (300 |iM), and HbO (20 pM) (a, Group lA) before (control; solid circles) and 
after (open circles) 30-minute hypoxia followed by 30-minute reoxygenation in 
Krebs solution at 37�C or (b, Group IB) before (control; solid circles) and after 
(open circles) 60-minute hypoxia followed by 30-minute reoxygenation in Krebs 
solution at 37°C. Data are shown as mean 士 SEM. *p less than 0.05, **p less than 
0.01 compared with the control (n = 6, paired t test). 
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Fig 3.3 Original tracings of bradykinin (BK, -10—6 log M)-induced relaxation in 
coronary micro arteries precontracted by U46619 (10 nM) with presence of Indo (7 
|iM), L-NNA (300 loM), and HbO (20 [iM) (a, Group lA) before (control) and after 
30-minute hypoxia followed by 30-minute reoxygenation in Krebs solution at 37�C 
or (b, Group IB) before (control) and after 60-minute hypoxia followed by 30-
minute reoxygenation in Krebs solution at 37°C. 
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Fig 3.4 Concentration-relaxation curves for bradykinin in the U46619 (10 nM)— 
precontracted microarteries (see protocol) with the presence of Indo (7 L-
NNA (300 |iM), and HbO (20 [iM) (a, Group IIA) before (control; solid circles) 
and after (open circles) 60-min hypoxia followed by 30-min reoxygenation in ST 
at 37�C or (b, Group IIB) 60-min hypoxia followed by 30-min reoxygenation in 
Krebs (solid circles) or in ST (open circles) at 4 � C Data are shown as mean 士 SEM. 
less than 0.05, less than 0.01 compared with the control (n = 6). Paired t 
test in (a) and unpaired t test in (b). 
62 
Chapter 3 H-R, ST nicorandil & EDHF in CA 
a 
iO:.:.分 
# •• .L ' . fn.: 
f T ‘ '7' i 
J " : " f . r / 
f ； / <} 
f � - . , • / 
t: \ ^ 
!： 《 
： i •'： • 
•i • i J / Control , ISO iO f:::: s •rc 4::. r. / I 
I U/ \ 
徽 M ‘ 
f .,/ 
，： m ‘ / / - . " • …Hfc 
b 
a 1 
广 J - ' -9 -V/ ^  
t ； ,? •t .... i V -； . f v.： 
’ :!. I ‘ 
7 1 ； / 1； 
/ ；O丨 ； 
./： rL:. iC � ：： 
•r • • r： 
:! :l: 





Fig 3.5 Original tracings of bradykinin (BK, -10—6 log M)-induced relaxation in 
coronary microarteries precontracted by U46619 (10 nM) with the presence of Indo 
(7 [iM), L - N N A (300 |iM), and HbO (20 J I M ) (a, Group I I A ) before (control) and 
after 60-min hypoxia followed by 30-min reoxygenation in ST at 37°C or (b, 
Group IIB) 60-min hypoxia followed by 30-min reoxygenation in Krebs or in ST at 
4 � C 
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Fig 3.6 Concentration-relaxation curves for bradykinin in the U46619 (10 nM)— 
precontracted microarteries (see Methods) with the presence of Indo (7 jiM), L-
NNA (300 \lM), and HbO (20 |iM) after exposure to (a, Group IIIA) Krebs 
solution without (solid circles) or with (open circles) nicorandil at 37°C for 60-min 
hypoxia or (b, Group IIIB) ST solution without (open circles) or with (solid circles) 
nicorandil at 37°C for 60-min hypoxia or (c, Group IIIC) ST solution without 
(open circles) or with (solid circles) nicorandil at 4 � C for 60-min hypoxia. Data 
are shown as mean 士 SEM.杯p less than 0.05, less than 0.01 compared with 
nicorandil treatment group (n = 6, unpaired t test). 
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Fig 3.7 Original tracings of bradykinin (BK, -10—6 log M)-induced relaxation in 
coronary microarteries precontracted by U46619 (10 nM) with presence of Indo (7 
jiM), L - N N A (300 jiM), and HbO (20 |aM) after exposure to (a, Group I I I A ) Krebs 
solution without or with nicorandil at 37�C for 60-min hypoxia or (b, Group IIIB) 
ST solution without or with nicorandil at 37�C for 60-min hypoxia or (c, Group 
IIIC) ST solution without or with nicorandil at 4 � C for 60-min hypoxia 
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Chapter 4 
Hypoxia-reoxygenation in cardiac microveins: 
combined effect with cardioplegia and temperature 
on the endothelial function 
4.1 Abstract 
Objective This study was designed to investigate the effects of H-R with or without 
ST solution on EDHF-mediated relaxation in porcine cardiac veins under clinically 
relevant temperatures. 
Methods The microveins (diameter 200 to 450 |iM) were normalized in a 
myograph at 37°C and subjected to hypoxia (P02<5mmHg) for 30 min in Krebs 
solution or for 60 min in Krebs or in ST at 37�C or 4�C, followed by 30-min-
reoxygenation. The microvein was precontracted with U46619 (-7 logM) and the 
EDHF-mediated relaxation was induced by BK (-10—6 logM) in the presence of 
Indo (7 | iM)，L-NNA (300 |iM), and HbO (20 i^M) to eliminate the effects of N O 
and PGI2. 
Results The maximal EDHF-mediated relaxation was significantly reduced after 
30-minute-hypoxia (38.7±2.0% vs. 61.1±2.3%, n=8, p<0.001). It was also 
significantly reduced after 60-minute-hypoxia in either Krebs or ST at 37°C (Krebs: 
27.8±1.2% vs. 56.6±2.5%, n=8, p<0.001; ST: 23.8±4.1% vs. 57.1±1.5o/o, n=8, 
p<0.001). The relaxation was significantly less after prolonged H-R in Krebs 
(p<0.001). Incubation of the artery in Krebs or ST at 4 � C also reduced the EDHF-
mediated relaxation (Krebs: 25.3±3.3%, n二6, p<0.001; ST: 29.1±4.4%, n二6, 
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p<0.001). However, there were no significant differences between Krebs and ST 
regarding the relaxation at 37°C or 4 � C (p>0.05). 
Conclusions We conclude that 1) H-R impairs EDHF-mediated relaxation in the 
coronary microveins and the injury is more severe during prolonged H-R. 2) ST 
does not provide protection to the EDHF-mediated relaxation impaired by H-R at 
37�C or 4�C. 
4.2 Introduction 
H-R (or ischemia-reperfusion) injury involves damage to myocytes as well 
as the coronary circulation (the vascular smooth muscle and the endothelium). The 
injury to myocytes may directly reduce cardiac contractility. The injury to the 
coronary circulation may change coronary vascular tone and resistance and, 
therefore, affect coronary flow during the reperfiision period. Reduction of 
coronary flow may damage myocardial perfusion and this, in addition to the 
ischemia-reperfusion injury to the myocardium, may further damage myocardial 
function. This functional change may cause mortality and morbidity in cardiac 
surgery. In the past, the myocyte injury has been extensively studied. However, 
only in recent years have studies been focused on H-R injury to coronary 
circulation [Maczewski and Beresewicz, 1998; Ren et al, 2001]. It has been 
demonstrated that both NO [Hein, et al 2003; Lefer, 1995], and EDHF [Liu and 
Flavahan, 1997; Ren et al, 2002]—mediated relaxations may be affected by H-R 
injury in coronary arteries. However, the effect of H-R on endothelial function in 
coronary venous system has not been studied yet. 
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Until now, ischemia-reperfusion injury remains the major cause of cardiac 
dysfunction in open heart surgery including heart transplantation. Cardioplegia 
was designed to protect the heart from ischemia-reperfusion injury. Although 
blood cardioplegia is popular in current cardiac surgery, ST is still used either as 
crystalloid cardioplegia or the basis of blood cardioplegia in combination with 
hypothermia or normothermia. ST has also been used in donor heart preservation 
under hypothermia for transplantation and has been demonstrated to be effective in 
protecting the myocardium against ischemia [Demertzis et al, 1993:. 
Hyperkalemia (potassium at high concentration), as the key component, 
contributes to cardiac protection by depolarizing the myocyte membrane and 
causing asystole, which avoids the depletion of the high-energy phosphate pool by 
ischemia and conserves the myocardial energy reserves [Allen and Buckberg, 
1999]. However, studies also showed that cardioplegia damages coronary 
endothelial function [Mankad et al, 1991; Sellke et al, 1993]. Our previous studies 
further demonstrated that in both large and microcoronary arteries, EDHF-
mediated function is impaired by hyperkalemic solutions such as ST [He et al, 
1996; He, 1997; Ge and He, 1999; Yang et al, 2003]. 
In blood vessels, endothelium plays an important role in regulating the 
activity of the underlying vascular smooth muscle. Endothelium-dependent 
relaxation is known to be due to a variety of different endothelium-derived 
relaxing factors. These include NO [Ignarro et al, 1987; Palmer et al, 1987], PGI2 
Moncada and Vane, 1978], and EDHF. The nature of EDHF has not been 
70 
Chapter 4 H-R ST & EDHF in CV 
identified [Cohen and Vanhoutte, 1995; Feletou and Vanhoutte, 2000; Vanhoutte, 
1998] although EETs [Yang et al, 2003], anandamide, the potassium ion, H2O2, 
citrulline, NHS, and nucleotides (ATP) [Vanhoutte, 1998] have been suggested to 
be EDHF. NO and EDHF are thought to be the two major mechanisms in the 
endothelium-smooth muscle interaction which is particularly important in 
maintaining adequate vascular tone. Further, it has been demonstrated that EDHF 
itself plays a role in blood flow homoeostasis in both conduit and resistance 
vessels under the physiological states, and may be a crucial compensatory or 
reserve mechanism for the maintenance of nutritive organ blood flow after 
inhibition or impairment of the NO/PGI2 pathway, particularly in the coronary 
microarteries [Feletou and Vanhoutte, 2000; Vanhoutte, 1998: • 
As to the coronary venous system (cardiac veins), it collects one-third of 
the blood of the coronary circulation and is considered to be an important site for 
the blood-tissue exchange of water and nutrients, as well as a possible determinant 
of ventricular distensibility. It is suggested that coronary vein is of resistance to 
coronary flow under conditions of arteriolar dilatation [Chilian et al, 1989；. 
Although the coronary venous system possesses 7% of total coronary vascular 
resistance in resting condition, its contribution greatly increases to 31% under 
vasodilated condition and acts as a potential modulator of coronary blood flow. In 
our lab, we have recently demonstrated that both NO and EDHF are involved in 
the regulation of the vascular tone in the coronary arterial and venous systems 
although the amount of NO release and the EDHF-mediated relaxation and 
71 
Chapter 4 H-R ST & EDHF in CV 
associated hyperpolarization are less significant in the vein than in the artery in the 
coronary system [Zhang et al, 2004]. In the physiological condition, this weak 
endothelial function of the cardiac vein may be enough for the normal distribution 
of coronary blood flow. However, when the coronary venous system contributes a 
greater fraction of total coronary resistance under a pathological condition such as 
when the heart is subjected to ischemia-reperfusion injury, the endothelial response 
of cardiac veins may act as a more important factor on the cardiac function. 
Preservation of this function in the cardiac vein may become important. For 
example, during cardiac surgery, when the retrograde cardioplegia is delivered 
from the coronary sinus through the cardiac venous system, the protection of the 
endothelial function in the venous system may prove to be an important clinical 
issue. 
Taken together, during open heart surgery, the coronary endothelium may 
be damaged by both ischemia-reperfusion and cardioplegia. Subsequently, this 
may affect cardiac function immediately after cardiac surgery and cause mortality 
or morbidity. Since the coronary microvascular system plays the key role in the 
regulation of myocardial perfusion, the investigation on the combined effects of 
cardioplegia and H-R on the endothelial function in the coronary microvascular 
system is particularly important. In addition, temperature is another factor that 
may also affect the endothelial function. 
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The present study was therefore designed to examine the effects of H-R 
with or without ST under normothermia or hypothermia on EDHF-mediated 
relaxation in porcine cardiac veins. 
4.3 Experimental design and analysis 
4.3.1 Vessel Preparation 
Upon receipt of the heart, intramyocardial coronary microveins (usually 
adjacent to the tertiary branches of the left anterior descending artery) with 
diameters of 200 to 450 jim were carefully dissected and removed under a 
microscope, with care taken to protect the endothelium. The vessels were cleaned 
of fat and connective tissue and cut into cylindrical rings of 2-mm length under a 
microscope. The rings were then set up in a 4-channel myograph (Model 610M; J. 
P. Trading, Aarhus, Denmark) as described in General Methods (See Chapter 2. 1). 
4. 3. 2 Normalization 
The ring was guided onto a suitable length of two stainless steel wires (40 
jLiM in diameter) through its lumen, and fixed tightly in a 4-channel myograph 
(Model 610M; J. P. Trading, Aarhus, Denmark). After the normalization described 
in General Methods (See Chapter 2. 1), the passive transmural pressure reached 9.8 
±0.5 mm Hg in cardiac microveins when the rings were set at a resting diameter of 
0.9 times the diameter at the transmural pressure of 30mmHg in the veins. This 
degree of passive tension at this setting is the "passive" or "resting" situation in the 
absence of constricting tone and maintained throughout the experiments. 
4.3.3 Hypoxia 
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During normalization or relaxation studies, the solution was aerated with a 
gas mixture of 95% O2 and 5% CO2 (normoxia, the partial pressure of oxygen 
(PO2) was more than 200 mmHg). Hypoxic condition was induced by switching 
bubbling gas from 95% O2 and 5% CO2 to 95% N2 and 5% CO2 (hypoxia, P02< 
5mmHg) in the plastic cover-sealed chamber. PO2 was measured by an Oxygen 
Meter (Model 781; Strathkelvin Instrument, Glasgow, Scotland, UK) as described 
in General Methods (see Chapter 2. 1). 
Protocol 
All rings were equilibrated for at least 30 minutes before and after 
normalization. The following protocol was used. 
4.3.4 Effect of H-R on EDHF-mediated relaxation in cardiac 
microveins 
Two cardiac veins were allocated into two groups. One was incubated in 
Krebs solution at 37�C and subjected to hypoxia (P02<5mmHg) for 30 minutes 
followed by 30-minute-reoxygenation (n=8). In this group of experiment, before 
(as the control) and after H-R, the EDHF-mediated relaxation was induced by BK 
(Group lA). Similarly, the EDHF-mediated relaxation was observed in the rings 
incubated in Krebs solution for 60-min-hypoxia followed by 30-min reoxygenation 
(n=8, Group IB). 
4.3.5 Combined effects of H-R and ST solution on EDHF-mediated 
relaxation in cardiac microveins 
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The rings were incubated in Krebs solution (as the control) at 37°C and the 
EDHF-mediated relaxation was induced by BK. After this, the rings were washed 
with Krebs solution and then incubated in ST at 37�C, subjected to hypoxia for 60-
min followed by 30-min-reoxygenation (n=8). The EDHF-mediated relaxation 
was then induced by BK again (Group IIA). 
Two rings from the same microvein were allocated into two groups. One 
was incubated in ST and the other in Krebs (as the control) at 4°C for 60-min-
hypoxia, followed by 30-min-reoxygenation. The EDHF-mediated relaxation to 
BK was established (Group IIB). 
4.3.6 Data analysis 
Relaxation is expressed as the percentage decrease in isometric force 
induced by U46619. Mean maximal relaxation for each group was calculated from 
the maximal relaxation of different rings induced by BK. The effective 
concentration of bradykinin that caused 50% of maximal relaxation was defined as 
E C 5 0 . The E C 5 0 was determined from each concentration-relaxation curve by a 
logistic, curve-fitting equation: E = MA^/ (A? + K^), where E is response, M is 
maximal relaxation, A is concentration, K is E C 5 0 concentration, and p is the slope 
parameter. A computerized program was used for the curve fitting. From this 
fitted equation, the mean E C 5 0 士 SEM was calculated for each group. 
4.4 Results 
4.4.1 Resting force 
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With regard to the resting force, there were no significant differences 
among the veins incubated with Krebs and ST solution either at 37°C or at 4°C for 
H-R {p > 0.05). Table 4.1 gives the details of the resting force in these microveins. 
4.4.2 U466i9-induced contraction force 
The concentration of U46619 varied from -7 logM to -6.5 logM to maintain a 
similar stable contraction force between the control and H-R condition in each 
group (p>0.05). Table 4.2 gives the details of the U466i9-induced precontraction 
before and after H-R in each group. 
4.4.3 Partial pressure of oxygen in hypoxia 
The normal oxygen pressure (>200mmHg) was quickly lowered to 30 
mmHg in 5 min and further lowered to less than 5 mmHg in another 10 min and 
maintained a low level throughout the experiment. In 30-min-hypoxia group, the 
partial pressure of oxygen was 4.5±0.6 mmHg and in 60-min-hypoxia group, it was 
2.2±0.3 mmHg (Fig 4.1). 
4.4.4 EDHF-mediated relaxation after H-R in Krebs solution at 
37�C 
After incubation in Krebs solution for H-R, BK-induced, EDHF-mediated 
relaxation was siginificantly reduced. The maximal relaxation was reduced from 
61.1% 士 2.30/0 in control to 38.7% 士 2.0% after 30-min hypoxia {p < 0.001，95% 
CI: 17.3% to 27.6%; Fig 4.2a, 4.3a). It was also reduced from 56.6% 士 2.5o/o to 
27.8% 士 1.20/0 {p = 0.000, 95% CI: 20.6% to 36.9%) after 60-min hypoxia. Further, 
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the reduction of the relaxation was more severe during prolonged H-R (27.8% 士 
1.2% vs. 38.7% 士 2.0o/O,;7 = 0.000, 95% CI: -15.8% to -5.9%, Fig 4.2b, 4.3b). 
H-R did not change the EC50 value of BK. It was -8.08 ± 0.18 log M vs.-
7.78 士 0.16 log M in the 30-min hypoxia group {p = 0.23, 95% CI: -0.84 to 0.24 
log M). However, after 60-min hypoxia, The E C 5 0 of BK was right shift from -
8.36 士 0.13 to -8.07 士 0.14 log M (p = 0.043, 95% CI: -0.56 to -0.01 log M). 
4.4.5 EDHF-mediated relaxation after exposure to H-R in ST 
solution at different temperature 
Exposure to ST solution at 37�C for 60-min-hypoxia significantly 
decreased EDHF-mediated relaxation from 57.1% 士 1.5o/o to 23.8% 士 4.1o/o {p = 
0.000, 95% CI: 24.1% to 42.5%, Fig 4.3a, 4.4a) with unchanged EC50 (-8.02 士0.14 
vs. -8.13 士 0.10 log M in the control group,;? =0.41, 95% CI: -0.19 to 0.41 log M). 
Comparing ST with Krebs solution, there were no significant differences regarding 
the relaxation (23.8% 士 4.1o/o vs. 27.8% 士 1.2o/o,;?=0.37, 95% CI: -13.2% to 5.2%). 
Incubation of the vein in Krebs or ST at 4°C for 60-minute hypoxia also 
reduced the EDHF-mediated relaxation to BK (Krebs: 25.3% 士 3.3o/o,;?<0.001; ST: 
29.1% 士 4.40/0, ;?<0.001). However, there were no significant differences between 
Krebs and ST regarding the relaxation {p = 0.50, 95% CI: -16.08% to 8.42%, Fig 
4.3b, 4.4b). With regard to the EC50, there were also no differences (-8.31 士 0.22 
vs. -8.19 士 0.21 log M in the control group,/? = 0.70, 95% CI: -0.55 to 0.80 log M). 
Further, there were no significant differences regarding the relaxation after 
exposure to ST at either 37�C or 4 � C {p = 0.40, 95% CI: -7.99% to 18.65%). 
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4.5 Discussion 
The present study demonstrates in porcine cardiac veins that (1) H-R 
impairs EDHF-mediated relaxation in the cardiac veins and the injury is more 
severe during prolonged H-R; and (2) under the condition of either profound 
hypothermia (4�C) or normothermia (37�C), ST does not provide protection to the 
EDHF-mediated relaxation impaired by H-R. 
4.5.1 Effect of H-R on EDHF-mediated relaxation 
Although the functional consequences of depriving a tissue of its blood 
supply have been appreciated for many years, the cardiovascular diseases that are 
initiated by local or systemic tissue ischemia remain the chief cause of death in the 
world [Donna et al, 2000]. The high morbidity and mortality of these diseases 
have focused the attention of physicians on restoring blood flow to the ischemia 
tissue in order to prevent tissue necrosis and regain organ function. It has become 
apparent that reperfusion, the restoration of blood flow after a period of ischemia, 
can place ischemic organs at risk of further cellular necrosis and thereby limit the 
recovery of function. It is widely recognized that the microvasculature, 
particularly the endothelial cells lining blood vessels, is very vulnerable to the 
deleterious consequences of ischemia and reperfusion. Evidence that myocardial 
ischemia leads to coronary endothelial dysfunction was first obtained by Ku [29' 
who showed that a 90-min period of ischemia followed by 1-hour reperfusion was 
associated with a decreased endothelium-dependent relaxation in response to 
thrombin in canine coronary arteries. Later studies found that NO-mediated 
78 
Chapter 4 H-R ST & EDHF in CV 
relaxation was impaired by H-R. Although the effect of H-R on membrane 
hyperpolarization has been studied [Siegel et al, 1992], the effect of that on EDHF-
mediated relaxation in coronary venous system was not reported yet. 
In the present study, after 30-minute hypoxia followed by 30-minute 
reoxygenation, EDHF-mediated ( L - N N A , HbO, and Indo-resistant) relaxation was 
significantly reduced. Furthermore, after 60-minute hypoxia followed by 30-
minute reoxygenation, this relaxation was fiirther reduced. These results showed 
that the EDHF-mediated relaxation is impaired by the H-R in the cardiac veins and 
the injury is more severe during prolonged H-R. 
In the present study, the U466i9-induced contraction was slightly affected by 
H-R. To fairly compare the relaxation, a similar precontraction force was essential 
and this was achieved in the present study by adding a higher concentration of 
U46619 (between 100-1000 nM) after H-R to reach a similar precontraction (Table 
4.2). 
4.5.2 Combined effects of H-R with ST solution on EDHF-
mediated relaxation 
The extracellular type of preservation solution ST was initially designed to 
eliminate the H-R injury of myocardium and has been demonstrated to be effective 
in cardiac protection. However, recent studies have provided evidence of the 
impairment of this solution on the endothelial function [Ge and He, 2000]. The 
combined effect of H-R and ST on the EDHF-related endothelial function under 
clinically relevant temperatures remains unknown and therefore this became one of 
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the aims of the present study. The results from this study indicate that exposure to 
ST solution at 4°C or at 37°C for 60-minute hypoxia reduced EDHF-mediated 
relaxation. ST does not provide protection to the EDHF-mediated relaxation 
impaired by H-R. 
With regard to the mechanism of reduced EDHF-mediated relaxation after 
exposure to ST during H-R, it is most likely related to the high K+ concentration 
(the potassium [K+] concentration is 20 mM) that reduces the EDHF-mediated 
relaxation by affecting K+ channels and prolonging the membrane depolarization 
Ge and He, 2000; He et al, 1997], as shown in the present study, H-R itself 
damages EDHF-mediated function and this damage can not been eliminated by ST. 
4.5.3 Clinical implications 
Coronary venous system collects one-third blood of the coronary 
circulation and is considered to be important sites for the blood-tissue exchange of 
water and nutrients. Apart from the physiological role of the coronary venous 
system, the understanding of the coronary venous system has direct pathological 
and clinical implications. During cardiac surgery, the heart is inevitably subjected 
to ischemia and subsequent reperfusion injury. Hyperkalemic solutions are 
commonly used in cardiac surgery to protect the heart in order to produce better 
postoperative recovery of myocardial function. The solution is usually perfused 
from the coronary artery for delivery to the cardiac muscle. However, retrograde 
perfusion of cardioplegic solutions from the coronary venous system through the 
coronary sinus in the right atrium to the cardiac muscle has been indicated under a 
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number of situations such as when the coronary arteries are stenotic. The present 
study indicates that under the normothermia and hypothermic condition, ST does 
not provide protection to the EDHF-mediated relaxation impaired by H-R. 
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Table 4.1 Resting Force in Porcine Cardiac veins 
Resting force (mN) 
Group Control H-R p 95%CI 
lA 2.0 ±0.3 1.9 ±0.2 .1 -0.1-0.3 
IB 1.8 ±0.3 1.9±0.：3 .2 -0.3-0.1 
IIA 2.2 ±0.3 1/7 ±0.2 .1 -0.1 � 0 . 9 
IIB 2.5 ±0.2 2.2 ±0.4 .5 -0.7-1.2 
Values are mean 士 SEM. Group I, Effect of H-R on resting force in cardiac veins; 
group lA: 30-min hypoxia in Krebs solution at 37�C; group IB: 60-min hypoxia in 
Krebs solution at 37�C. Group II, Effect of H-R and ST solution on resting force 
in cardiac veins; group IIA: 60-min hypoxia in ST at 37°C; group IIB: 60-min 
hypoxia in ST at 4°C. The p values between paired groups were calculated with 
paired t test. CI = confidence interval. 
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Table 4.2 U466i9-induced contraction before and after H-R in each group. 
U46619 Contraction (mN) U46619 Concentration (Log M) 
Group Control H-R p 95%CI Control H-R p 95%CI 
lA 5.44 ±0.75 5.15 ±0.83 0.297 -0.32 � 0 . 9 1 -6.90 ±0.07 -6.84 ±0.08 0.431 -0.26 ~ 0.13 
IB 4.93 士 0.69 4.78 ±0.65 0.692 -0.71 � 1 . 0 2 -6.94 土 0.06 -6.89 ± 0.09 0.470 -0.20-0.10 
IIA 6.93 ± 1.29 6.51 ±0.96 0.376 -0.63 � 1 . 4 7 -6.88 ±0.08 -6.75 ±0.07 0.055 -0.26 � 0 . 0 1 
IIB 6.95 土 1.36 7.69 ±0.88 0.658 -4.34 ~ 2.87 -6.79 士 0.09 -6.80 ±0.10 0.953 -0.30-0.32 
Values are mean 士 SEM. Group I, Effect of H-R on U466i9-induced contraction in 
cardiac veins; group lA: 30-min hypoxia in Krebs solution at 37°C; group IB: 60-
min hypoxia in Krebs solution at 37°C. Group II, Effect of H-R and ST solution on 
U466i9-induced contraction in cardiac veins; group IIA: 60-min hypoxia in ST at 
37°C; group IIB: 60-min hypoxia in ST at 4°C. The p values between paired 
groups were calculated with paired t test. CI = confidence interval. 
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Fig 4.1 Partial pressure of oxygen (PO2) in hypoxia. Data are shown as mean 士 
SEM. 
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Fig 4.2 Concentration-relaxation curves for bradykinin in the U46619 (100 nM)— 
precontracted cardiac veins with the presence of indomethacin (7 |iM), N^-nitro-L-
arginine (300 ^iM), and oxyhemoglobin (20 |iM) (a, Group lA) before (control; 
solid circles) and after (open circles) 30-minute hypoxia followed by 30-minute 
reoxygenation in Krebs solution at 37�C or (b, Group IB) before (control; solid 
circles) and after (open circles) 60-minute hypoxia followed by 30-minute 
reoxygenation in Krebs solution at 37°C. Data are shown as mean 士 SEM. *p less 
than 0.05, **p less than 0.01 compared with the control (n = 8, paired t test). H/R: 
hypoxia/reoxygenation. 
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Fig 4.3 Original tracings of bradykinin (BK, -10� -6 log M)-induced relaxation in 
cardiac veins precontracted by U46619 (U, 100 nM) with presence of indomethacin 
(I, 7 \iU), N^-nitro-L-arginine (L, 300 |iM), and oxyhemoglobin (Hb, 20 |iM) (a, 
Group lA) before (control) and after 30-minute hypoxia followed by 30-minute 
reoxygenation in Krebs solution at 37�C or (b, Group IB) before (control) and after 
60-minute hypoxia followed by 30-minute reoxygenation in Krebs solution at 37°C. 
H/R: hypoxia/reoxygenation; ST: St Thomas solution. 
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Fig 4.4 Concentration-relaxation curves for bradykinin in the U46619 (100 nM)— 
precontracted microveins (see Methods) with the presence of indomethacin (7 jiM), 
N^-nitro-L-arginine (300 |iM), and oxyhemoglobin (20 |iM) (a, Group IIA) before 
(control; solid circles) and after (open circles) 60-min hypoxia followed by 30-min 
reoxygenation in ST at 37°C or (b, Group IIB) 60-min hypoxia followed by 30-min 
reoxygenation in Krebs (solid circles) or in ST (open circles) at 4°C Data are 
shown as mean 士 SEM *p less than 0.05, **p less than 0.01 compared with the 
control (n = 6). Paired t test in (a) and unpaired t test in (b). H/R: hypoxia 
reoxygenation; ST: St Thomas solution. 
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Fig 4.5 Original tracings of bradykinin (BK, -10� -6 log M)-induced relaxation in 
cardiac veins precontracted by U46619 (U, 100 nM) with the presence of 
indomethacin (I, 7 joM), N -nitro-L-arginine (L, 300 |iM), and oxyhemoglobin (Hb, 
20 jiM) (a, Group IIA) before (control) and after 60-min hypoxia followed by 30-
min reoxygenation in ST at 37°C or (b, Group IIB) 60-min hypoxia followed by 
30-min reoxygenation in Krebs or in ST at 4°C. H/R: hypoxia reoxygenation; ST: 
St Thomas solution 
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Chapter 5 
General Discussion 
5.1 EDHF-mediated endothelial function in porcine 
coronary circulation 
BK, a potent endogenous vasodilator, is released from ischemic 
myocardium and plays an important role in the regulation of coronary circulation 
in both physiological and pathological conditions [Miura et al., 1999]. BK 
interacts with B2 receptors on the endothelial cells and increases the level of 
9+ 
intracellular free Ca through the receptor-coupled G protein(s), leading to release 
of a variety of endothelium-dependent vasoactive substances [Baydoun and 
Woodward, 1991; Graier et al., 1992]. In animal models, tyrosine phosphorylation 
of endothelial Bi-receptors stimulates a transient dissociation of the interaction 
with eNOS and phopholipase A2 to release NO and vasoactive metabolites of AA, 
respectively [Regoli and Barabe, 1980; Baydoun and Woodward, 1991; Marrero et 
al., 1999]. Therefore, BK-induced release of endothelium-derived vasodilators is 
receptor-dependent. The present study used BK to induce the stimulated release of 
EDHF to cause relaxation in porcine coronary vessels. 
5.1.1 EDHF in porcine coronary microarteries 
Although the nature of EDHF is not finally identified, it has been 
demonstrated that EDHF plays an important role in endothelium-dependent 
hyperpolarization and relaxation in both coronary conduit and resistance arteries. 
Studies have found that NO inhibitors do not completely block the effect of NO 
Cohen et al, 1997; Ge et al, 2000]. By directly measuring NO with microsensor 
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m e t h o d , o u r l abo ra to ry p r o v i d e d u n d o u b t e d e v i d e n c e tha t e v e n w i t h the p r e s e n c e 
of L - N N A at a high concentration, there is still a certain amount of N O released 
from endothelium in response to the stimulation of BK [Ge et al, 2000; Yang et al, 
2003]. The fact that the residual NO may be completely scavenged by HbO [Ge et 
al, 2000] suggests that HbO should be added in EDHF studies. Therefore, in the 
present study, all experiments were performed in the presence of L-NNA (NOS 
inhibitor), indo (COX inhibitor) and HbO (NO scavenger) to ensure that the 
relaxation is truly mediated by EDHF. 
5.1.2 EDHF in porcine cardiac veins 
Although the structure is different between coronary artery and cardiac 
vein, the potential role of endothelium in regulating vascular tone is similar in 
these two vasculatures. In bioassay experiments the production of EDRF was 
measured from cultured human umbilical vein endothelial cells [Forstermann et al, 
1989]. Subsequently, studies found that vasodilatation caused by BK is mediated 
via PGI2 released from endothelial cells or from smooth muscle (subendothelial) 
cells in canine mesenteric veins [Okamura and Toda, 1989]. In porcine pulmonary 
veins, Zellers and colleagues demonstrated that ET-1 is a potent vasoconstrictor 
and stimulates the release of NO and PGI2, which oppose the contractions to the 
peptide. However, as in the coronary circulation, there is an L - N N A and Indo-
resistant relaxation in cardiac veins that may be due to the third relaxing factor-
EDHF or merely mediated by residual NO as aforementioned. Therefore, a series 
of experiments were designed in this study to clarify this issue. 
The present study demonstrated the existence of EDHF in the cardiac 
venous system by measurement of vasorelaxation of the smooth muscle cell in the 
coronary circulation. With treatment of Indo, L-NNA , and HbO to exclude the 
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effects of NO and PGI2, porcine cardiac veins precontracted with U46619 exhibited 
obvious relaxation to BK. This demonstrated again the existence of the "true 
effect" of EDHF in the porcine coronary venous system and provided evidence that 
the EDHF-mediated endothelial function plays a role in the regulation of the 
venous tone. With regard to the comparison with porcine coronary arteries at the 
same range of diameter, the EDHF-mediated relaxation is less in the cardiac veins. 
In the arteries incubated with Krebs solution, the BK-induced, EDHF-mediated 
relaxation is more that 80%, whereas it is approximately 60% in cardiac veins. 
This difference may be explained by the different structures of these two types of 
vascular bed. 
5.2 Alteration of EDHF-mediated function after exposure 
to H-R 
The consequences of H-R injury on myocytes have been studied 
intensively. Previous investigations of methods of myocardial protection during 
global and regional ischemia have focused on resultant alterations in myocardial 
function. However, recent studies have demonstrated that H-R also impairs the 
endothelial function in the coronary circulation. To better understand the effects of 
H-R on the individual EDRFs is of great significance. Therefore, in the present 
study, the EDHF-mediated endothelial function of coronary microarteries or 
cardiac veins was examined after H-R. 
5.2.1 In coronary microarteries 
In the present study, after 30-min hypoxia followed by 30-min 
reoxygenation, EDHF-mediated ( L - N N A , HbO, and Indo-resistant) relaxation was 
significantly reduced to 59.9%. Furthermore, after 60-min hypoxia followed by 
30-min reoxygenation, this relaxation was further reduced to 44.4%. These results 
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showed that the BK-induced, EDHF-mediated relaxation is impaired by H-R in the 
coronary microarteries and the injury is more severe during prolonged H-R. 
5.2.2 In cardiac veins 
Similar to coronary microarteries, after 30-min hypoxia followed by 30-
min reoxygenation, EDHF-mediated relaxation was significantly reduced to 38.7%. 
Furthermore, after 60-min hypoxia followed by 30-min reoxygenation, this 
relaxation was further reduced to 27.8%. These results showed that the EDHF-
mediated relaxation is impaired by H-R in the cardiac veins and the injury is more 
severe during prolonged H-R. 
In addition to the EDHF-related function, effects of H-R on the contractility 
of coronary microarteries or cardiac veins were also examined in this study. After 
H-R, the vascular contractility of U46619 was slightly affected. However, the 
clinical implication of the decreased contractile response after exposure to H-R is 
unknown and is to be further studied. 
5.3 Alteration of EDHF-mediated function after exposure 
to ST solution under H-R 
Cardioplegia and organ preservation solutions are widely used in cardiac 
surgery to achieve immediate heart arrest and protect the myocardium from 
ischemia-reperfusion injury. During the preservation and operation of the heart, 
the coronary vasculature is inevitablely exposed to the cardioplegic solutions. 
Hyperkalemia (potassium at high concentration), as the key component in 
cardioplegia, contributes to cardiac protection while also damages coronary 
endothelial function. Our previous study provided further evidence for its 
unfavorable effect on a particular relaxing factor, i.e., EDHF. Taken together with 
the previous discussion, during open heart surgery, the coronary endothelium may 
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be damaged by both ischemia-reperflision and cardioplegia. In the present study, 
the combined effect of cardioplegia and H-R on the endothelial function in the 
coronary microvascular system was investigated. 
5.3.1 In coronary microarteries 
ST cardioplegia is often used in cardiac surgery combined with 
hypothermia or normothermia. In the present study, the clinical setting was 
simulated by immersing porcine coronary microarteries into ST solution at 37°C or 
4°C for 60-min hypoxia. After this procedure, the BK-induced, EDHF-mediated 
relaxation was examined. We have found that under the condition of either 4°C or 
37°C, ST does not provide protection to the EDHF-mediated relaxation impaired 
by H-R although its detrimental effect at 37°C is eliminated at 4°C, suggesting that 
it would have better effect under hypothermia. 
5.3.2 In cardiac veins 
Coronary venous system collects one-third blood of the coronary 
circulation and is considered to be important sites for the blood-tissue exchange of 
water and nutrients. Apart from the physiological role of the coronary venous 
system, the understanding of the coronary venous system has direct pathological 
and clinical implications. The present study indicates that under the normothermia 
and hypothermic condition, the endothelial function of coronary microveins is 
damaged by H-R and this damage can not be eliminated by ST, ever under 
hypothermia. 
5.4 EDHF-mediated function in nicorandil-supplemented 
solution under H-R in coronary microarteries 
As a KATP channel opener with a nitrate-like effect, the potent vasodilator 
nicorandil has been demonstrated effective in myocardial protection against 
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ischemia-reperfusion [Markham et al, 2000]. In our study, the effect of nicorandil 
on the coronary endothelial function was evaluated. 
In the present study, exposure to hypoxia for 60 minutes in Krebs solution 
at 37°C followed by 30-min reoxygenation significantly decreased BK-induced, 
EDHF-mediated relaxation whereas addition of nicorandil to Krebs solution at 37 
°C during 60-min hypoxia recovered the reduced relaxation from 44.4% to 81.7%. 
This finding stimulates further investigation on the impact of nicorandil 
supplementation in cardiac surgery. 
The effect of ST solution with/without nicorandil under H-R on EDHF-
mediated relaxation in porcine coronary microarteries was examined at different 
temperatures. After exposure to ST solution at 37°C or 4°C for 60-min hypoxia, 
the EDHF-mediated relaxation was reduced and this relaxation was significantly 
increased by the addition of nicorandil. With regard to the mechanism of the 
protective effect of nicorandil, it is most likely related to its effect to open K+ 
channels and therefore compensates or is synergetic to the mechanism of EDHF-
mediated smooth muscle relaxation. The recovery of EDHF function in 
nicorandil-containing ST solution supports the use of nicorandil as an additive to 
ST cardioplegia to preserve the endothelial cell function in order to improve the 
performance of hearts subjected to global myocardial ischemia during cardiac 
surgery. The protective effect of nicorandil from this study provides new insights 
into the further development of cardioplegia and organ preservation solutions. 
5.5 Clinical Implication 
5.5.1 H-R injury 
H-R is a major problem in open-heart surgery, including heart 
transplantation. In the past, many studies have been focused on the H-R injury on 
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the myocardium. However, comprehensive evaluation regarding the effect of H-R 
injury should include the estimation of the impact on vascular endothelial function 
as well. The present study demonstrated that after exposure to H-R, the EDHF-
mediated endothelial function was impaired in both coronary microarteries and 
cardiac veins. These factors should be taken into account in cardiac surgery. 
5.5.2 H-R injury and cardioplegic solution 
During open-heart surgery, cardioplegic solutions are used to protect the 
heart from ischemia-reperfusion injury. The cardioplegic solution is usually 
perfused from the coronary artery for delivery to the cardiac muscle. However, 
retrograde perfusion of cardioplegic solutions from the coronary venous system 
through the coronary sinus in the right atrium to the myocardium has been 
indicated under a number of situations such as when the coronary arteries are 
stenotic. Therefore, it is essential to investigate the combined effect of H-R and 
cardioplegia on the coronary circulation. The present study demonstrated that 
exposure to ST solution under 4°C or 37°C does not provide protection to the 
EDHF-mediated relaxation impaired by H-R, although its detrimental effect at 
37°C is eliminated at 4°C in coronary microarteries. Similarly, ST solution does 
not provide protection to the EDHF-mediated relaxation impaired by H-R at 37°C 
or at 4°C in cardiac veins. This study promotes further investigations on 
preservation solutions for cardiac surgery. 
5.5.3 Nicorandil-supplementation in cardioplegia solutions 
Our study demonstrated that H-R impairs the EDHF-mediated coronary 
endothelial function. Exposure to ST solution under the condition of profound 
hypothermia or normothermia does not provide protection to the EDHF-mediated 
relaxation impaired by H-R. However, addition of nicorandil to Krebs or ST 
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during hypoxia may restore the EDHF-mediated function in porcine coronary 
microarteries. These results defined the role of nicorandil and are in favor of the 
continuous use of it in cardioplegia from the angle of endothelial protection and 
therefore have strong clinical implications in cardiac surgery. 
5.6 Limitation of the study 
First, in the present study, we only concentrated on the isometric force 
study by using myograph to investigate the endothelial function of porcine 
coronary vessels. In the future we will use more techniques, such as 
microelectrode, NO meter and etc, to further investigate the function of 
endothelium. Secondly, although the porcine model is believed to be a good model 
of human being, the interspecies variation should not be neglected. Thirdly, the 
present study was performed in isolated porcine coronary vessels only, although 
this is the most suitable method to clearly demonstrate the effects of EDHF with 
complete exclusion of the influence of NO and PGI2, as well as the impact of 
coronary flow and other physiological factors. Further in vivo animal or human 
studies are necessary to confirm the in vitro findings and these will be addressed in 
our future studies. Therefore, the results from these in vitro investigations could 
not be simply transferred to the clinical setting. Finally, the observed effect on the 
vessels may not completely reflect the effect in the heart as a whole. 
5.7 Future investigations 
The future work will be the extension of the work described in this thesis. 
1. To investigate the possibly protective effects of KCOs or antioxidants or other 
substances on EDHF-mediated function in coronary/pulmonary vessels. 
2. To investigate the combined effects of other organ preservation solutions and 
H-R on the EDHF function in coronary/pulmonary circulation. 
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3. To organize clinical trial on the protective effect of KCOs or other additives 
5.8 Conclusions 
The present study concentrated on the EDHF-mediated endothelial function 
in the porcine coronary circulation. In addition to the effect of H-R on endothelial 
function in coronary microarteries and cardiac veins, the combined effects of H-R 
and ST solution on EDHF-mediated relaxation under clinically relevant 
temperatures in these vessels. Further, the effect of nicorandil supplementation in 
solutions under H-R on EDHF-mediated endothelial function in coronary 
microarteries was also investigated. From these investigations, we may conclude 
that: 
1 With the abolition of the effects of NO and PGI2, EDHF exists in both porcine 
coronary microarteries and cardiac veins. 
2 EDHF plays a more important role in BK-induced relaxation in both porcine 
coronary microarteries and micro-veins but presents more relaxation in the 
arteries than in the veins. 
3 H-R impairs EDHF-mediated relaxation in both coronary microarteries and 
cardiac veins and the injury is more severe during prolonged H-R. 
4 Exposure to ST solution under the condition of profound hypothermia (4°C) or 
normothermia (37�C) does not provide protection to the EDHF-mediated 
relaxation impaired by H-R, although its detrimental effect at 37°C is 
eliminated at 4°C in coronary microarteries. 
5 Under the condition of profound hypothermia (4�C) or normothermia (37�C), 
ST solution does not provide protection to the EDHF-mediated relaxation 
impaired by H-R at 37°C or at 4°C in cardiac veins. 
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6 Additition of nicorandil to Krebs or ST during hypoxia under normothermia or 
profound hypothermia may restore the EDHF-mediated endothelial flinction in 
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